WO2020113962A1 - Application of bacterial laccase cota protein in degradation of mycotoxins - Google Patents

Application of bacterial laccase cota protein in degradation of mycotoxins Download PDF

Info

Publication number
WO2020113962A1
WO2020113962A1 PCT/CN2019/095955 CN2019095955W WO2020113962A1 WO 2020113962 A1 WO2020113962 A1 WO 2020113962A1 CN 2019095955 W CN2019095955 W CN 2019095955W WO 2020113962 A1 WO2020113962 A1 WO 2020113962A1
Authority
WO
WIPO (PCT)
Prior art keywords
cota protein
bacterial laccase
feed
bacterial
sequence
Prior art date
Application number
PCT/CN2019/095955
Other languages
French (fr)
Chinese (zh)
Inventor
赵丽红
马秋刚
计成
郭永鹏
Original Assignee
中国农业大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国农业大学 filed Critical 中国农业大学
Publication of WO2020113962A1 publication Critical patent/WO2020113962A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Definitions

  • the invention belongs to the technical field of enzyme engineering, and specifically relates to the application of the bacterial laccase CotA protein in the degradation of mycotoxins, in particular the simultaneous degradation of aflatoxin and zearalenone and the like.
  • Mycotoxins are secondary metabolites of molds and have carcinogenic, genotoxic, reproductive toxicity, neurotoxicity, and immunosuppressive effects. When animals eat moldy diets, growth inhibition, increased disease susceptibility, metabolic disorders, and reproduction disorders Waiting for the symptoms of mycotoxin poisoning. In addition, mycotoxin metabolites can remain in animal-derived food and enter the human body through the food chain, threatening human health. Grains and grains will be infected with toxin-producing molds in the field. If the ambient temperature and humidity are suitable, the molds will continue to grow and reproduce during processing, transportation, and storage, and the toxin content will continue to increase.
  • Aflatoxin is mainly produced by Aspergillus flavus and Aspergillus parasite. Among them, aflatoxin B1 is the most toxic and harmful. Aflatoxin B1 is 10 times more acutely toxic than potassium cyanide and 68 times more arsenic. Its molecular structure contains difuran ring and Xanthone ring is closely related to its toxicity and carcinogenicity.
  • Zearalenone also known as F-2 toxin, is a non-steroidal mycotoxin produced by Fusarium graminearum, which has an estrogen effect, and its chemical name is 6-(10-hydroxy-6-oxy- Undecenyl) ⁇ -raysulactone, in which the lactone bond and the hydroxyl group at the C4 position of the benzene ring are the major toxic groups of zearalenone.
  • Mycotoxin biodegradation refers to the conversion of mycotoxins into non-toxic or low-toxic metabolites under the action of microorganisms and the specific enzymes they produce. It has the advantages of safety, high efficiency and environmental protection. It is the detoxification of mycotoxins in current feed and food Development trend.
  • the enzymes reported at home and abroad that can degrade aflatoxin and zearalenone are mainly peroxidases, such as horseradish peroxidase, manganese peroxidase, etc.
  • laccase derived from fungi has also been reported It has the activity of degrading aflatoxin and zearalenone.
  • Peroxidase needs hydrogen peroxide as a substrate in the process of catalytic degradation of aflatoxin and zearalenone, and fungal laccase degrades aflatoxin and zearalenone requires the participation of a mediator, so peroxidation
  • the effectiveness and safety of mycotoxin and fungal laccase in the detoxification of mycotoxins in feed and food need further evaluation.
  • proteins with aflatoxin degradation activity also include aflatoxin oxidase ADTZ derived from Armillaria mellea and F420H2-dependent reductase FDR derived from Mycobacterium; proteins with zearalenone degradation activity also include Lactone hydrolase ZHD101 derived from Gliocladium rosenbergii and zearalenone degrading enzyme ZENdease-N2 derived from B. grisea
  • the purpose of the present invention is to provide the application of bacterial laccase CotA protein in the detoxification of mycotoxins.
  • the present invention provides a bacterial laccase CotA protein.
  • the amino acid sequence of the bacterial laccase CotA protein is:
  • the amino acid sequence of the bacterial laccase CotA protein is: has at least 70% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
  • the amino acid sequence of the bacterial laccase CotA protein is: having at least 75% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the bacterial laccase CotA protein Sequence of functions.
  • the amino acid sequence of the bacterial laccase CotA protein is: has at least 80% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
  • the amino acid sequence of the bacterial laccase CotA protein is: has at least 85% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
  • nucleotide sequence encoding the bacterial laccase CotA protein is:
  • nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
  • the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 70% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
  • the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 75% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
  • the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 80% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
  • the nucleotide sequence encoding the bacterial laccase CotA protein is: having a sequence identity of at least 85% with the nucleotide sequence shown in SEQ ID NO:2.
  • the present invention also provides the application of the bacterial laccase CotA protein in the degradation of mycotoxins, the mycotoxins are aflatoxins B1, B2, G1, G2, M1, M2, corn red One or more of mycoenol, zearalenol, or zearalenol.
  • the bacterial laccase CotA protein is derived from Bacillus.
  • the Bacillus can be Bacillus licheniformis, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus, Bacillus lentus Or Bacillus clausii, preferably Bacillus licheniformis.
  • amino acid sequence of the bacterial laccase CotA protein may be:
  • nucleotide sequence encoding the bacterial laccase CotA protein is:
  • nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
  • a food or feed additive comprising bacterial laccase CotA protein and a physiologically acceptable carrier, the content of the laccase CotA protein is 1-10%.
  • the physiologically acceptable carrier is selected from one or more of maltodextrin, milk powder, limestone, cyclodextrin, wheat, wheat bran, rice, rice bran, sucrose, starch, Na 2 SO 4 , talc or PVA Species.
  • amino acid sequence of the bacterial laccase CotA protein may be:
  • microecological preparations which are Bacillus licheniformis, Bacillus subtilis, Bifidobacterium bifidum, Enterococcus faecalis, Enterococcus faecium, Enterococcus lactis, Lactobacillus acidophilus, Lactobacillus casei , Lactobacillus germani subsp.
  • lactis Lactobacillus plantarum, Pediococcus lactis, Pediococcus pentosus, Candida utilis, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium adolescentis, Thermophile One or more of Streptococcus, Lactobacillus reuteri, Bifidobacterium animalis, Aspergillus oryzae, Bacillus lentus, Bacillus pumilus, Lactobacillus cellobiose, Lactobacillus fermentum and Lactobacillus delbrueckii subsp.
  • the additive when used in silage or cattle feed, it further contains at least one of Propionibacterium, Lactobacillus brucelli and Lactobacillus paracasei; or the additive is used in poultry, pigs and aquatic products When feeding animal feed, it also contains Bacillus coagulans and/or Brevibacillus lateralis.
  • the additives further include additional enzymes; the additional enzymes are selected from: aflatoxin detoxification enzymes, zearalenone lactone enzymes, fumonisin carboxylesterase, fumonisin aminotransferase , Aminopolyol amine oxidase, deoxyfusarium oxytetracycline epoxide hydrolase, carboxypeptidase, Aspergillus niger aspartic protease PEPAa, PEPAb, PEPAc or PEPAd, elastase, aminopeptidase, pepsin, stomach Protease-like proteases, trypsin, trypsin-like proteases, bacterial proteases, enzymes involved in starch metabolism, fiber degradation, lipid metabolism, proteins or enzymes involved in glycogen metabolism, amylase, arabinase, arabinofuranase, Catalase, cellulase, chitinase, rennet, cut
  • the additional enzymes
  • the content of the micro-ecological preparation is 0-20%;
  • the content of the additional enzyme is 0-9%.
  • the preparation method of the above additives includes the following steps: the bacterial laccase CotA protein is mixed with a physiologically acceptable carrier to prepare an additive containing the laccase CotA protein, further, or in accordance with the microecological preparation and other enzymes according to certain Proportional mixing to obtain an additive; the CotA protein content of the additive is 1-10%.
  • the bacterial laccase CotA protein physiologically acceptable carrier: microecological preparation: the mass ratio of the additional enzyme can be: 1:70:20:9 or 2:70:20:8 or 3:70: 20:7 or 4:70:20:6 or 5:70:20:5 or 6:70:20:4 or 7:70:20:3 or 8:70:20:2 or 9:70:20: 1 or 10:70:20:0.
  • the invention also provides a method for degrading mycotoxins, including the following steps: treating the material containing mycotoxins with the bacterial laccase CotA protein or the additive according to the invention, the material includes but not limited to food, feed, feed materials, Grain, grain oil, grain processing by-products or milk.
  • the material further includes tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged grain, full-price feed for pigs, chickens, cattle, sheep, aquatic animals, Concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed.
  • the present invention also provides the application of the bacterial laccase CotA protein or the food or feed additive in the degradation of mycotoxins in food and/or feed, characterized in that the food and And/or feed includes but is not limited to food, feed, feed raw materials, grain, grain oil, grain processing by-products or milk.
  • the invention also provides the bacterial laccase CotA protein or the additive used in tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged grain, pig, chicken, cattle, sheep and aquatic animals Application of mycotoxin in detoxification of full price feed, concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed.
  • the invention provides the application of the bacterial laccase CotA protein in the degradation of mycotoxins.
  • the enzyme is derived from beneficial microorganisms and is suitable for application in food and feed; the experiment confirmed that the bacterial laccase CotA protein can simultaneously degrade aflatoxin and Zearalenone and other toxins.
  • Figure 1 shows the SDS-PAGE diagram of the recombinant plasmid PET31b-CotA expression product after purification; lane 1 is the purified recombinant CotA protein, and lane M is the protein molecular weight standard (116, 66.2, 45, 35, 25, 18.4, 14.4kDa) );
  • FIG. 2 shows the results of HPLC analysis of recombinant CotA protein degrading AFB1 (A is AFB1 blank control group, B is AFB1 plus CotA protein treatment group);
  • Figure 3 shows the results of HPLC analysis of recombinant CotA protein degrading ZEN (A is ZEN blank control group, B is ZEN plus CotA protein treatment group);
  • Figure 4 shows the degradation of AFB1 and ZEN by CotA protein under different pH conditions
  • Figure 5 shows the degradation of AFB1 and ZEN by CotA protein under different temperature conditions.
  • biochemical reagents used in the examples are all commercially available reagents, and the technical means used in the examples are conventional means used by those skilled in the art.
  • E. coli expression vector PET-31b The E. coli expression vector PET-31b, the cloned strain E. coli DH5 ⁇ , and the expression strain E. coli Rosseta (DE3) were all purchased from Invitrogen. Restriction endonucleases and DNA ligases were purchased from NEB Company, aflatoxin and zearalenone standard products were purchased from sigma company, and other reagents were domestic analytical pure.
  • Example 1 Obtaining and expressing CotA protein
  • the genomic DNA of Bacillus licheniformis was used as the amplification template to amplify the CotA protein coding gene, and then construct a recombinant expression vector containing CotA protein coding gene sequence and its engineered bacteria, and express the CotA protein. Specific steps are as follows:
  • NdeI and XhoI were selected as the restriction sites, and the upstream primer P1 and downstream primer P2 were designed and synthesized by Shanghai Shengong Bioengineering Technology Co., Ltd. Design the sequence of upstream primer P1 and downstream primer P2 as follows:
  • Upstream primer P1 5′ATGAAACTTGAAAAATTCGTTG3′
  • Downstream primer P2 5′TTATTGATGACGAACATCTG3′
  • the genomic DNA of Bacillus licheniformis was used as the template for amplification.
  • the reaction conditions were:
  • the amplification conditions were: pre-denaturation at 95°C for 5min; denaturation at 95°C for 30s; annealing at 50°C for 30s, extension at 72°C for 1min and 30s reaction for 30 cycles; 72°C for complete extension for 10min.
  • the PCR amplified products were subjected to 1% agarose gel electrophoresis, and the PCR products were recovered using agarose gel DNA recovery kit.
  • the PCR product recovered in the previous step and the PET-31b plasmid were digested with NdeI and XhoI, and the digestion system was as follows:
  • Digestion conditions 37°C water bath for 30min.
  • the digested product was subjected to 1% agarose gel electrophoresis, and the PCR product and plasmid digested fragments were recovered using an agarose gel DNA recovery kit.
  • the PCR product and plasmid recovered by the above digestion were ligated overnight at 16°C with T4 DNA ligase; the ligation product was transformed into E. coli competent cell DH5 ⁇ , screened by Amp resistant plate, positive transformants were picked, the transformed plasmid was extracted, and single and double Digestion verification and sequencing confirmed that the correct recombinant strain DH5 ⁇ /PET-31b-CotA was obtained.
  • the recombinant E. coli Rosseta (DE3) transformed with PET-31b-CotA plasmid was inoculated in 5mL liquid LB medium for activation overnight, and transferred to a 500mL Erlenmeyer flask with a volume of 300mL at a ratio of 1:100, 180r/min Incubate at 37°C until the OD600 is 0.6, add a final concentration of 0.1mM IPTG to induce the expression of the target protein.
  • the fermentation broth was collected, centrifuged at 12000rpm for 30min at 4°C, and the supernatant was discarded; the cells were resuspended with phosphate buffer at pH 7.0, centrifuged at 12000rpm for 30min at 4°C, the supernatant was discarded, and the cells were washed three times.
  • the bacterial cells were then resuspended in a binding buffer of 1 mg/mL, sonicated, centrifuged at 12000 rpm for 10 min at 4°C, and the supernatant was collected and filtered.
  • Ni2 + -NTA nickel ion affinity chromatography column
  • chromatographic column Agilent C18 column, 4.6mm ⁇ 150mm ⁇ 5 ⁇ m
  • mobile phase methanol-water (45:55); flow rate: 1mL/min
  • pump pressure 75bar
  • Sample volume 20 ⁇ L
  • collection time 20 minutes.
  • Example 3 The effect of pH on the degradation of aflatoxin B1 and zearalenone by CotA protein
  • the reaction system used in Case Example 2 430 ⁇ L buffer (0.1M sodium citrate buffer, pH6; 0.1M sodium phosphate buffer, pH7-8; 0.1M glycine -NaOH buffer, pH 9-10), 20 ⁇ L CotA protein (10 ⁇ g), 50 ⁇ L zearalenone solution. After the reaction was carried out at 37°C for different time (1, 3, 6, 9, 12h), 500 ⁇ L of methanol was added to terminate the reaction. The method described in Case Example 2 was used to detect the residual ZEN content in the system. The results are shown in Figure 4. Under neutral and alkaline conditions, CotA protein degrades ZEN with relatively high activity, and the optimal pH is 8.0.
  • Example 4 The effect of temperature on the degradation of aflatoxin B1 and zearalenone by CotA protein
  • the reaction system used in Case Example 2 was used: 430 ⁇ L buffer (0.1M sodium phosphate buffer, pH8), 20 ⁇ L CotA protein (10 ⁇ g), 50 ⁇ L aflatoxin B1 Solution or zearalenone solution.
  • the reaction was carried out at different temperatures (30, 40, 50, 60, 65, 70, 75, 80°C) for 30 minutes, and then 500 ⁇ L of methanol was added to terminate the reaction.
  • the method described in Case 2 was used to detect the residual toxin content in the system. The results are shown in Figure 5.
  • the optimal temperature for CotA protein degradation AFB1 is 70°C
  • the optimal temperature for ZEN degradation is 75°C.
  • CotA protein degradation of aflatoxin B1 and zearalenone enzyme activity is defined as the amount of enzyme required to degrade 1 ⁇ g of toxin per minute.
  • Table 1 shows the kinetic parameters of CotA catalytic degradation of aflatoxin B1 and zearalenone
  • the AFM1, AFG1, zearalenol and zearalenol were dissolved in dimethyl sulfoxide to make a 20 ⁇ g/mL mother liquor, and the test was carried out according to the following 500 ⁇ L reaction system: 430 ⁇ L sodium phosphate buffer (0.1M, pH6. 0-8.0), 20 ⁇ L CotA protein (10 ⁇ g), 50 ⁇ L mother liquid of various toxins. The system without CotA protein was used as a control. After the reaction was carried out at 37°C for 12h, 500 ⁇ L of methanol was added to terminate the reaction. High-performance liquid chromatography was used to detect whether the CotA protein had degrading activity against several toxins according to the change in the concentration of each toxin. Specific embodiments are as in Example 2. The efficiency of CotA for catalytic degradation of AFM1, AFG1, zearalenol and zearalenol is shown in Table 2.
  • Example 7 An additive and preparation method thereof
  • Example 8 An additive and preparation method thereof
  • Example 9 An additive and preparation method thereof
  • Example 10 An additive and its preparation method
  • AFB1 in naturally moldy corn was treated with the additives described in Example 8.
  • Simulated gastric juice accurately weigh 2g of corn containing naturally moldy AFB1, then add 2mg of additive, put it in a 100mL Erlenmeyer flask, add 25mL of PBS (0.1M pH6.0), adjust the pH to 6.8, and mix well. Add 1mL of prepared amylase solution, and digest at 39°C, 150r/min for 2h. Add 10mL of 0.2M HCl, adjust the pH to 2.0 with 1M HCl or 1M NaOH solution, add 1mL of freshly prepared acid protease (50000U/g), mix well, seal with parafilm, and incubate at 39°C for 6h (150r/min) ).
  • the degradation rate of AFB1 in natural moldy corn was determined to be 91.24%.
  • Simulated gastric juice accurately weigh 2g of ZEN mildewed DDGS, add 2mg of additive, put it in a 100mL Erlenmeyer flask, add 25mL of PBS (0.1M pH 6.0), adjust the pH to 6.8, and mix well. Add 1mL of prepared amylase solution, and digest at 39°C, 150r/min for 2h. Add 10mL 0.2M HCl, adjust the pH to 2.0 with 1M HCl or 1M NaOH solution, add 1mL of freshly prepared acidic protease (50000U/g), mix well, seal with parafilm, and incubate at 39°C for 6h (150r/min) ).
  • the degradation rate of ZEN in moldy DDGS was determined to be 93.23%.

Abstract

Application of bacterial laccase CotA protein and additive formed thereby in the degradation of mycotoxins, which specifically relate to the application thereof in the detoxification of aflatoxin and zearalenone in food, feed and raw material, grain, grain oil, grain byproducts, DDGS, milk, tea, Chinese herbal medicines and byproducts thereof, aging grains, complete feed for various animals, concentrated feed, premixed feed and silage, feed for aquatic animals, feed for pets and feed for fur animals. Experiments verify that the bacterial laccase CotA protein may simultaneously degrade the aflatoxin and the zearalenone independent of any mediator.

Description

细菌漆酶CotA蛋白在降解霉菌毒素中的应用Application of bacterial laccase CotA protein in the degradation of mycotoxins
本申请要求于2018年12月07日提交中国专利局、申请号为201811492897.9、发明名称为“细菌漆酶CotA蛋白在降解霉菌毒素中的应用”的中国专利申请的优先权,其全部内容通过引用结合在本申请中。This application requires the priority of the Chinese patent application filed on December 07, 2018 in the Chinese Patent Office with the application number 201811492897.9 and the invention titled "Application of Bacterial Laccase CotA Protein in Degrading Mycotoxins", the entire content of which is cited by reference Incorporated in this application.
技术领域Technical field
本发明属于酶工程技术领域,具体涉及细菌漆酶CotA蛋白在降解霉菌毒素中的应用,特别是同时降解黄曲霉毒素和玉米赤霉烯酮及其类似物中的应用。The invention belongs to the technical field of enzyme engineering, and specifically relates to the application of the bacterial laccase CotA protein in the degradation of mycotoxins, in particular the simultaneous degradation of aflatoxin and zearalenone and the like.
背景技术Background technique
霉菌毒素是霉菌的次级代谢产物,具有致癌作用、遗传毒性、生殖毒性、神经毒性和免疫抑制作用,动物采食霉变日粮后会出现生长抑制、疾病易感性增加、代谢紊乱、繁殖障碍等霉菌毒素中毒症状,另外霉菌毒素代谢产物可以残留在动物源性食品中,通过食物链进入人体威胁人类健康。粮食谷物在田间就会感染产毒素霉菌,如果环境温度、湿度适宜,在加工、运输、储存过程中霉菌会继续生长繁殖,毒素含量会继续增加。据国际粮农组织(FAO)估计,全世界每年有25%的谷物受到霉菌毒素污染,平均有2%不能食用,加之因毒素污染导致的人和动物中毒、疾病和死亡,造成的社会经济损失难以估量。黄曲霉毒素主要由黄曲霉和寄生曲霉产生,其中黄曲霉毒素B1的毒性和危害最大,黄曲霉毒素B1急性毒性是氰化钾的10倍,砒霜的68倍,其分子结构中双呋喃环及氧杂奈邻酮环与其毒性及致癌性密切相关。玉米赤霉烯酮又称F-2毒素,是一种主要由禾谷镰刀菌产生的非类固醇类、具有雌激素作用的霉菌毒素,化学名为6-(10-羟基-6-氧基-十一碳烯基)β-雷锁酸内脂,其中内酯键和苯环C4号位上的羟基是玉米赤霉烯酮的主要毒性基团。Mycotoxins are secondary metabolites of molds and have carcinogenic, genotoxic, reproductive toxicity, neurotoxicity, and immunosuppressive effects. When animals eat moldy diets, growth inhibition, increased disease susceptibility, metabolic disorders, and reproduction disorders Waiting for the symptoms of mycotoxin poisoning. In addition, mycotoxin metabolites can remain in animal-derived food and enter the human body through the food chain, threatening human health. Grains and grains will be infected with toxin-producing molds in the field. If the ambient temperature and humidity are suitable, the molds will continue to grow and reproduce during processing, transportation, and storage, and the toxin content will continue to increase. The International Food and Agriculture Organization (FAO) estimates that 25% of the world’s grains are contaminated with mycotoxins every year, and an average of 2% are inedible. In addition, poisoning, disease, and death of humans and animals caused by toxin contamination make social and economic losses difficult. Estimate. Aflatoxin is mainly produced by Aspergillus flavus and Aspergillus parasite. Among them, aflatoxin B1 is the most toxic and harmful. Aflatoxin B1 is 10 times more acutely toxic than potassium cyanide and 68 times more arsenic. Its molecular structure contains difuran ring and Xanthone ring is closely related to its toxicity and carcinogenicity. Zearalenone, also known as F-2 toxin, is a non-steroidal mycotoxin produced by Fusarium graminearum, which has an estrogen effect, and its chemical name is 6-(10-hydroxy-6-oxy- Undecenyl) β-raysulactone, in which the lactone bond and the hydroxyl group at the C4 position of the benzene ring are the major toxic groups of zearalenone.
霉菌毒素生物降解是指在微生物及其产生的特效酶的作用下将霉菌毒素转化成无毒或低毒的代谢产物,具有安全、高效和环保等优点,是当下饲料和食品中霉菌毒素脱毒的发展趋势。目前国内外报道的能够降解黄 曲霉毒素和玉米赤霉烯酮的酶主要是过氧化物酶,如辣根过氧化物酶、锰过氧化物酶等,此外来源于真菌的漆酶也被报道具有降解黄曲霉毒素和玉米赤霉烯酮活性。过氧化物酶在催化降解黄曲霉毒素和玉米赤霉烯酮过程中需要以过氧化氢为底物,真菌漆酶催化降解黄曲霉毒素和玉米赤霉烯酮需要介体的参与,因此过氧化物酶和真菌漆酶用于饲料和食品中霉菌毒素脱毒有效性和安全性亟需进一步评估。此外,具有黄曲霉毒素降解活性的蛋白还包括来源于假蜜环菌的黄曲霉毒素氧化酶ADTZ以及来源于分枝杆菌的F420H2依赖还原酶FDR;具有玉米赤霉烯酮降解活性的蛋白还包括来源于红粉粘帚霉的内酯水解酶ZHD101以及来源于葡萄顶枯病菌的玉米赤霉烯酮降解酶ZENdease-N2。Mycotoxin biodegradation refers to the conversion of mycotoxins into non-toxic or low-toxic metabolites under the action of microorganisms and the specific enzymes they produce. It has the advantages of safety, high efficiency and environmental protection. It is the detoxification of mycotoxins in current feed and food Development trend. The enzymes reported at home and abroad that can degrade aflatoxin and zearalenone are mainly peroxidases, such as horseradish peroxidase, manganese peroxidase, etc. In addition, laccase derived from fungi has also been reported It has the activity of degrading aflatoxin and zearalenone. Peroxidase needs hydrogen peroxide as a substrate in the process of catalytic degradation of aflatoxin and zearalenone, and fungal laccase degrades aflatoxin and zearalenone requires the participation of a mediator, so peroxidation The effectiveness and safety of mycotoxin and fungal laccase in the detoxification of mycotoxins in feed and food need further evaluation. In addition, proteins with aflatoxin degradation activity also include aflatoxin oxidase ADTZ derived from Armillaria mellea and F420H2-dependent reductase FDR derived from Mycobacterium; proteins with zearalenone degradation activity also include Lactone hydrolase ZHD101 derived from Gliocladium rosenbergii and zearalenone degrading enzyme ZENdease-N2 derived from B. grisea
越来越多证据表明,其他性质未明的酶也可能参与降解黄曲霉毒素和玉米赤霉烯酮这两种具有苯环和内酯环结构的霉菌毒素。因此,寻找和开发新的酶类,用于霉菌毒素的生物降解势在必行。There is increasing evidence that other unknown enzymes may also be involved in the degradation of aflatoxin and zearalenone, two mycotoxins with benzene ring and lactone ring structures. Therefore, it is imperative to find and develop new enzymes for the biodegradation of mycotoxins.
发明内容Summary of the invention
本发明的目的在于提供细菌漆酶CotA蛋白在霉菌毒素脱毒中的应用。用于谷物、粮食、饲料、食品、水果、牛奶等及其加工副产物、工业乙醇加工副产物DDGS、茶叶、中草药及其加工副产物、陈化粮、各种动物用全价饲料、浓缩饲料、预混合饲料及青贮饲料、水产动物饲料、宠物饲料和毛皮动物饲料等材料中霉菌毒素脱毒。The purpose of the present invention is to provide the application of bacterial laccase CotA protein in the detoxification of mycotoxins. Used in grain, grain, feed, food, fruit, milk, etc. and its processing by-products, industrial ethanol processing by-product DDGS, tea, Chinese herbal medicine and its processing by-products, aged grain, various animal feeds, concentrated feed , Premix feed and silage, aquatic animal feed, pet feed and fur animal feed and other materials detoxification of mycotoxins.
为此,本发明的技术方案如下:To this end, the technical solution of the present invention is as follows:
本发明提供了一种细菌漆酶CotA蛋白,所述细菌漆酶CotA蛋白的氨基酸序列为:The present invention provides a bacterial laccase CotA protein. The amino acid sequence of the bacterial laccase CotA protein is:
如SEQ ID NO.1所示序列;As shown in SEQ ID NO.1 sequence;
或者如SEQ ID NO.1所示序列中的一个或两个氨基酸残基被取代和/或缺失和/或插入;Or one or two amino acid residues in the sequence shown in SEQ ID NO. 1 are substituted and/or deleted and/or inserted;
或者与SEQ ID NO:1所示的氨基酸序列具有至少90%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。Or a sequence having at least 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of bacterial laccase CotA protein.
在本发明的一些具体实施方案中,所述细菌漆酶CotA蛋白的氨基酸 序列为:与SEQ ID NO:1所示的氨基酸序列具有至少70%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。In some specific embodiments of the present invention, the amino acid sequence of the bacterial laccase CotA protein is: has at least 70% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
在本发明的一些具体实施方案中,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少75%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。In some specific embodiments of the present invention, the amino acid sequence of the bacterial laccase CotA protein is: having at least 75% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the bacterial laccase CotA protein Sequence of functions.
在本发明的一些具体实施方案中,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少80%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。In some specific embodiments of the present invention, the amino acid sequence of the bacterial laccase CotA protein is: has at least 80% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
在本发明的一些具体实施方案中,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少85%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。In some specific embodiments of the present invention, the amino acid sequence of the bacterial laccase CotA protein is: has at least 85% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has the bacterial laccase CotA protein Sequence of functions.
在本发明的一些具体实施方案中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:In some specific embodiments of the invention, the nucleotide sequence encoding the bacterial laccase CotA protein is:
如SED ID NO.2所示序列;As shown in the sequence of SEDID NO.2;
或者如SED ID NO.2所示序列中的一个或两个核苷酸残基被取代和/或缺失和/或插入;Or one or two nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
或者与SEQ ID NO:2所示的核苷酸序列具有至少90%以上的序列一致性。Or it has at least 90% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
在本发明的一些具体实施方案中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少70%以上的序列一致性。In some specific embodiments of the present invention, the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 70% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
在本发明的一些具体实施方案中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少75%以上的序列一致性。In some specific embodiments of the present invention, the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 75% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
在本发明的一些具体实施方案中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少80%以上的序列一致性。In some specific embodiments of the present invention, the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 80% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
在本发明的一些具体实施方案中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少85%以上的序 列一致性。In some specific embodiments of the present invention, the nucleotide sequence encoding the bacterial laccase CotA protein is: having a sequence identity of at least 85% with the nucleotide sequence shown in SEQ ID NO:2.
在上述研究的基础上,本发明还提供了所述细菌漆酶CotA蛋白在降解霉菌毒素上的应用,所述的霉菌毒素为黄曲霉毒素B1、B2、G1、G2、M1、M2、玉米赤霉烯酮、玉米赤霉烯醇或玉米赤霉醇中的一种或多种。Based on the above research, the present invention also provides the application of the bacterial laccase CotA protein in the degradation of mycotoxins, the mycotoxins are aflatoxins B1, B2, G1, G2, M1, M2, corn red One or more of mycoenol, zearalenol, or zearalenol.
上述应用中,所述细菌漆酶CotA蛋白来源于芽孢杆菌。In the above application, the bacterial laccase CotA protein is derived from Bacillus.
上述应用中,所述芽孢杆菌可以为地衣芽孢杆菌(Bacillus licheniformis)、枯草芽孢杆菌(Bacillus subtilis)、解淀粉芽孢杆菌(Bacillus amyloliquefaciens)、短小芽胞杆菌(Bacillus pumilus)、迟缓芽孢杆菌(Bacillus lentus)或克劳氏芽胞杆菌(Bacillus clausii),优选为地衣芽孢杆菌(Bacillus licheniformis)。In the above application, the Bacillus can be Bacillus licheniformis, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus, Bacillus lentus Or Bacillus clausii, preferably Bacillus licheniformis.
上述应用中,其中所述细菌漆酶CotA蛋白的氨基酸序列可以为:In the above application, the amino acid sequence of the bacterial laccase CotA protein may be:
如SEQ ID NO.1所示序列;As shown in SEQ ID NO.1 sequence;
或者如SEQ ID NO.1所示序列中的一个或两个氨基酸残基被取代和/或缺失和/或插入;Or one or two amino acid residues in the sequence shown in SEQ ID NO. 1 are substituted and/or deleted and/or inserted;
或者与SEQ ID NO:1所示的氨基酸序列具有至少90%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。Or a sequence having at least 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of bacterial laccase CotA protein.
上述应用中,编码所述细菌漆酶CotA蛋白的核苷酸序列为:In the above application, the nucleotide sequence encoding the bacterial laccase CotA protein is:
如SED ID NO.2所示序列;As shown in the sequence of SEDID NO.2;
或者如SED ID NO.2所示序列中的一个或两个核苷酸残基被取代和/或缺失和/或插入;Or one or two nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
或者与SEQ ID NO:2所示的核苷酸序列具有至少90%以上的序列一致性。Or it has at least 90% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
一种食品或饲料添加剂,包含细菌漆酶CotA蛋白以及生理上可接受的载体,所述漆酶CotA蛋白的含量为1-10%。A food or feed additive comprising bacterial laccase CotA protein and a physiologically acceptable carrier, the content of the laccase CotA protein is 1-10%.
所述生理上可接受的载体选自麦芽糖糊精、奶粉、石灰石、环糊精、小麦、麦麸、稻米、米糠、蔗糖、淀粉、Na 2SO 4、滑石粉或PVA中的一种或多种。 The physiologically acceptable carrier is selected from one or more of maltodextrin, milk powder, limestone, cyclodextrin, wheat, wheat bran, rice, rice bran, sucrose, starch, Na 2 SO 4 , talc or PVA Species.
上述添加剂中,细菌漆酶CotA蛋白的氨基酸序列可以为:Among the above additives, the amino acid sequence of the bacterial laccase CotA protein may be:
如SEQ ID NO.1所示序列;As shown in SEQ ID NO.1 sequence;
或者如SEQ ID NO.1所示序列中的一个或两个氨基酸残基被取代和/或缺失和/或插入;Or one or two amino acid residues in the sequence shown in SEQ ID NO. 1 are substituted and/or deleted and/or inserted;
或者与SEQ ID NO:1所示的氨基酸序列具有至少90%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。Or a sequence having at least 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of bacterial laccase CotA protein.
上述添加剂中,还包括微生态制剂,所述微生态制剂为地衣芽孢杆菌、枯草芽孢杆菌、两歧双歧杆菌、粪肠球菌、屎肠球菌、乳酸肠球菌、嗜酸乳杆菌、干酪乳杆菌、德式乳杆菌乳酸亚种、植物乳杆菌、乳酸片球菌、戊糖片球菌、产朊假丝酵母、婴儿双歧杆菌、长双歧杆菌、短双歧杆菌、青春双歧杆菌、嗜热链球菌、罗伊氏乳杆菌、动物双歧杆菌、米曲霉、迟缓芽孢杆菌、短小芽孢杆菌、纤维二糖乳杆菌、发酵乳杆菌和德氏乳杆菌保加利亚亚种中的一种或多种,优选的,所述添加剂在用于青贮饲料或牛饲料时,还含有产丙酸杆菌、布氏乳杆菌和副干酪乳杆菌中的至少一种;或者所述添加剂在用于禽类、猪和水产养殖动物的饲料时,还含有凝结芽孢杆菌和/或侧孢短芽孢杆菌。The above additives also include microecological preparations, which are Bacillus licheniformis, Bacillus subtilis, Bifidobacterium bifidum, Enterococcus faecalis, Enterococcus faecium, Enterococcus lactis, Lactobacillus acidophilus, Lactobacillus casei , Lactobacillus germani subsp. lactis, Lactobacillus plantarum, Pediococcus lactis, Pediococcus pentosus, Candida utilis, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium adolescentis, Thermophile One or more of Streptococcus, Lactobacillus reuteri, Bifidobacterium animalis, Aspergillus oryzae, Bacillus lentus, Bacillus pumilus, Lactobacillus cellobiose, Lactobacillus fermentum and Lactobacillus delbrueckii subsp. bulgaricus, Preferably, when the additive is used in silage or cattle feed, it further contains at least one of Propionibacterium, Lactobacillus brucelli and Lactobacillus paracasei; or the additive is used in poultry, pigs and aquatic products When feeding animal feed, it also contains Bacillus coagulans and/or Brevibacillus lateralis.
上述添加剂中,所述添加剂还包括另外的酶;所述另外的酶选自:黄曲霉毒素去毒酶、玉米赤霉烯酮内酯酶、伏马毒素羧基酯酶、伏马毒素氨基转移酶、氨基多元醇胺氧化酶、脱氧瓜萎镰菌醇环氧化物水解酶、羧肽酶、黑曲霉天冬氨酸蛋白酶PEPAa、PEPAb、PEPAc或PEPAd,弹性蛋白酶、氨基肽酶、胃蛋白酶、胃蛋白酶样蛋白酶、胰蛋白酶、胰蛋白酶样蛋白酶、细菌蛋白酶、涉及淀粉代谢、纤维降解、脂质代谢的酶、涉及糖原代谢的蛋白质或酶、淀粉酶、阿拉伯糖酶、阿拉伯呋喃糖酶、过氧化氢酶、纤维素酶、几丁质酶、凝乳酶、角质酶、脱氧核糖核酸酶、表异构酶、酯酶、半乳糖苷酶、葡聚糖酶、葡聚糖裂解酶、内切葡聚糖酶、葡糖淀粉酶、葡萄糖氧化酶,葡糖苷酶,包括β-葡糖苷酶,葡糖醛酸酶、半纤维素酶、己糖氧化酶、水解酶、转化酶、异构酶、脂解酶、漆酶、裂解酶、甘露糖苷酶、氧化酶、氧化还原酶、果胶酸裂解、果胶乙酰酯酶、果胶去聚合酶、果胶甲酯酶、果胶分解酶、过氧化物酶、多铜氧化酶、酚氧化酶、植酸酶、多聚半乳糖醛酸酶、蛋白酶、鼠李-半乳糖醛酸酶、核糖核酸酶、非洲甜果素、转移酶、转运蛋白、转谷酰胺酶、木聚糖酶、己糖氧化酶和 酸性磷酸酶中的一种或多种。Among the above additives, the additives further include additional enzymes; the additional enzymes are selected from: aflatoxin detoxification enzymes, zearalenone lactone enzymes, fumonisin carboxylesterase, fumonisin aminotransferase , Aminopolyol amine oxidase, deoxyfusarium oxytetracycline epoxide hydrolase, carboxypeptidase, Aspergillus niger aspartic protease PEPAa, PEPAb, PEPAc or PEPAd, elastase, aminopeptidase, pepsin, stomach Protease-like proteases, trypsin, trypsin-like proteases, bacterial proteases, enzymes involved in starch metabolism, fiber degradation, lipid metabolism, proteins or enzymes involved in glycogen metabolism, amylase, arabinase, arabinofuranase, Catalase, cellulase, chitinase, rennet, cutinase, deoxyribonuclease, epimerase, esterase, galactosidase, glucanase, glucan lyase, internal Glucanase, glucoamylase, glucose oxidase, glucosidase, including β-glucosidase, glucuronidase, hemicellulase, hexose oxidase, hydrolase, invertase, isomerase Enzymes, lipolytic enzymes, laccases, lyases, mannosidases, oxidases, oxidoreductases, pectate cleavage, pectin acetylesterase, pectin depolymerase, pectin methylase, pectin degrading enzymes , Peroxidase, polycopper oxidase, phenol oxidase, phytase, polygalacturonase, protease, rhamno-galacturonase, ribonuclease, african sweetener, transferase, One or more of transporter, transglutaminase, xylanase, hexose oxidase, and acid phosphatase.
上述添加剂中,所述微生态制剂的含量为0-20%;In the above additives, the content of the micro-ecological preparation is 0-20%;
上述添加剂中,所述另外的酶的含量为0-9%。In the above additives, the content of the additional enzyme is 0-9%.
上述添加剂的制备方法,包括以下步骤:将细菌漆酶CotA蛋白与其生理上可接受的载体混合,配制成含有漆酶CotA蛋白的添加剂,进一步的,或者再与微生态制剂和另外的酶按一定比例混合,得到添加剂;该添加剂中CotA蛋白含量为1-10%。The preparation method of the above additives includes the following steps: the bacterial laccase CotA protein is mixed with a physiologically acceptable carrier to prepare an additive containing the laccase CotA protein, further, or in accordance with the microecological preparation and other enzymes according to certain Proportional mixing to obtain an additive; the CotA protein content of the additive is 1-10%.
上述添加剂中,细菌漆酶CotA蛋白:生理上可接受的载体:微生态制剂:另外的酶的质量比例可以为:1∶70∶20∶9或2∶70∶20∶8或3∶70∶20∶7或4∶70∶20∶6或5∶70∶20∶5或6∶70∶20∶4或7∶70∶20∶3或8∶70∶20∶2或9∶70∶20∶1或10∶70∶20∶0。Among the above additives, the bacterial laccase CotA protein: physiologically acceptable carrier: microecological preparation: the mass ratio of the additional enzyme can be: 1:70:20:9 or 2:70:20:8 or 3:70: 20:7 or 4:70:20:6 or 5:70:20:5 or 6:70:20:4 or 7:70:20:3 or 8:70:20:2 or 9:70:20: 1 or 10:70:20:0.
本发明还提供了一种降解霉菌毒素的方法,包括步骤如下:将细菌漆酶CotA蛋白或本发明所述的添加剂处理含有霉菌毒素的材料,该素材包括但不限于食品、饲料、饲料原料、粮食、粮油、粮食加工副产品或牛奶。The invention also provides a method for degrading mycotoxins, including the following steps: treating the material containing mycotoxins with the bacterial laccase CotA protein or the additive according to the invention, the material includes but not limited to food, feed, feed materials, Grain, grain oil, grain processing by-products or milk.
在本发明的一些具体实施方案中,所述素材还包括茶叶,中草药及其加工副产物,工业乙醇加工副产物DDGS,陈化粮,猪、鸡、牛、羊、水产动物用全价饲料、浓缩饲料、预混合饲料、青贮饲料、水产动物饲料、宠物饲料和/或毛皮动物饲料。In some specific embodiments of the present invention, the material further includes tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged grain, full-price feed for pigs, chickens, cattle, sheep, aquatic animals, Concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed.
在上述研究的基础上,本发明还提供了所述的细菌漆酶CotA蛋白或所述的食品或饲料添加剂在食品和/或饲料中霉菌毒素降解中的应用,其特征在于,所述食品和/或饲料包括但不限于食品、饲料、饲料原料、粮食、粮油、粮食加工副产品或牛奶。On the basis of the above research, the present invention also provides the application of the bacterial laccase CotA protein or the food or feed additive in the degradation of mycotoxins in food and/or feed, characterized in that the food and And/or feed includes but is not limited to food, feed, feed raw materials, grain, grain oil, grain processing by-products or milk.
本发明还提供了所述的细菌漆酶CotA蛋白或所述的添加剂在茶叶,中草药及其加工副产物,工业乙醇加工副产物DDGS,陈化粮,猪、鸡、牛、羊、水产动物用全价饲料、浓缩饲料、预混合饲料、青贮饲料、水产动物饲料、宠物饲料和/或毛皮动物饲料中霉菌毒素脱毒中的应用。The invention also provides the bacterial laccase CotA protein or the additive used in tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged grain, pig, chicken, cattle, sheep and aquatic animals Application of mycotoxin in detoxification of full price feed, concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed.
本发明的优点和有益效果:The advantages and beneficial effects of the present invention:
本发明提供了细菌漆酶CotA蛋白在降解霉菌毒素方面的应用,该酶来源于有益微生物适合在食品和饲料中应用;试验证实细菌漆酶CotA蛋 白能够不依赖任何介体同时降解黄曲霉毒素和玉米赤霉烯酮等多种毒素。The invention provides the application of the bacterial laccase CotA protein in the degradation of mycotoxins. The enzyme is derived from beneficial microorganisms and is suitable for application in food and feed; the experiment confirmed that the bacterial laccase CotA protein can simultaneously degrade aflatoxin and Zearalenone and other toxins.
附图说明BRIEF DESCRIPTION
图1所示为重组质粒PET31b-CotA的表达产物纯化后SDS-PAGE图;其中泳道1为纯化重组CotA蛋白,泳道M为蛋白分子量标准(116、66.2、45、35、25、18.4、14.4kDa);Figure 1 shows the SDS-PAGE diagram of the recombinant plasmid PET31b-CotA expression product after purification; lane 1 is the purified recombinant CotA protein, and lane M is the protein molecular weight standard (116, 66.2, 45, 35, 25, 18.4, 14.4kDa) );
图2所示为重组CotA蛋白降解AFB1的HPLC分析结果(A为AFB1空白对照组,B为AFB1加CotA蛋白处理组);Figure 2 shows the results of HPLC analysis of recombinant CotA protein degrading AFB1 (A is AFB1 blank control group, B is AFB1 plus CotA protein treatment group);
图3所示为重组CotA蛋白降解ZEN的HPLC分析结果(A为ZEN空白对照组,B为ZEN加CotA蛋白处理组);Figure 3 shows the results of HPLC analysis of recombinant CotA protein degrading ZEN (A is ZEN blank control group, B is ZEN plus CotA protein treatment group);
图4所示为不同pH条件下CotA蛋白对AFB1和ZEN的降解情况;Figure 4 shows the degradation of AFB1 and ZEN by CotA protein under different pH conditions;
图5所示为不同温度条件下CotA蛋白对AFB1和ZEN的降解情况。Figure 5 shows the degradation of AFB1 and ZEN by CotA protein under different temperature conditions.
具体实施方式detailed description
下面结合附图和具体实施例对本发明作进一步说明。如未特别指明,实施例中所用的生化试剂均为市售试剂,实施例中所用的技术手段为本领域技术人员用到的常规手段。The present invention will be further described below with reference to the drawings and specific embodiments. Unless otherwise specified, the biochemical reagents used in the examples are all commercially available reagents, and the technical means used in the examples are conventional means used by those skilled in the art.
在本发明实施例中使用的主要实验材料和试剂为:The main experimental materials and reagents used in the embodiments of the present invention are:
大肠杆菌表达载体PET-31b、克隆菌株大肠杆菌DH5α、表达菌株大肠杆菌Rosseta(DE3)均购自Invitrogen公司。限制性核酸内切酶和DNA连接酶购自NEB公司,黄曲霉毒素和玉米赤霉烯酮标准品购自sigma公司,其它试剂为国产分析纯。The E. coli expression vector PET-31b, the cloned strain E. coli DH5α, and the expression strain E. coli Rosseta (DE3) were all purchased from Invitrogen. Restriction endonucleases and DNA ligases were purchased from NEB Company, aflatoxin and zearalenone standard products were purchased from sigma company, and other reagents were domestic analytical pure.
实施例1 CotA蛋白的获得及表达Example 1 Obtaining and expressing CotA protein
以地衣芽孢杆菌基因组DNA为扩增模板,扩增CotA蛋白的编码基因,然后构建含有CotA蛋白编码基因序列的重组表达载体及其工程菌,并表达CotA蛋白。具体步骤如下:The genomic DNA of Bacillus licheniformis was used as the amplification template to amplify the CotA protein coding gene, and then construct a recombinant expression vector containing CotA protein coding gene sequence and its engineered bacteria, and express the CotA protein. Specific steps are as follows:
1、编码CotA蛋白基因的克隆1. Cloning of the gene encoding CotA protein
1.1按以下步骤提取地衣芽孢杆菌基因组DNA1.1 Follow the steps below to extract genomic DNA from Bacillus licheniformis
(1)从甘油管中接种划线于LB固体平板上,37℃静置培养12h。(1) Inoculate the LB solid plate from the glycerol tube and incubate at 37°C for 12h.
(2)从培养菌体的平板上挑取一单菌落接种于含5mL液体LB培养基中,180r/min,37℃条件下培养12h。(2) Pick a single colony from the plate of cultured cells to inoculate in 5mL liquid LB medium, 180r/min, and culture at 37℃ for 12h.
(3)将菌液分装到灭菌的1.5mL微量离心管中,12000r/min离心1min收集菌体,弃上清。(3) Separate the bacterial solution into a sterilized 1.5mL microcentrifuge tube, centrifuge at 12000r/min for 1min to collect the bacterial cells, and discard the supernatant.
(4)向留有菌体沉淀的离心管中加入500μL细胞悬浮液,枪头吹旋使菌体悬浮,37℃温浴60min;12000r/min离心1min收集菌体,弃上清。(4) Add 500 μL of the cell suspension to the centrifuge tube with the bacterial cell precipitate, whip the pipette tip to suspend the bacterial cell, warm bath at 37°C for 60 min; centrifuge at 12000 r/min for 1 min to collect the bacterial cell, and discard the supernatant.
(5)向菌体沉淀中加入225μL缓冲液A,振荡至菌体彻底悬浮。(5) Add 225 μL of buffer A to the bacterial pellet and shake until the bacterial pellet is completely suspended.
(6)向管子里加入10μL蛋白酶K溶液,颠倒混匀。(6) Add 10 μL of proteinase K solution to the tube and mix upside down.
(7)加入25μL裂解液S,颠倒混匀;57℃水浴放置20min,其间颠倒混匀1-2次。(7) Add 25 μL of lysis solution S, mix upside down; place in a 57°C water bath for 20 min, and mix upside down 1-2 times.
(8)加入250μL缓冲液B,振荡5s充分混匀。(8) Add 250 μL of buffer B, shake for 5 s and mix thoroughly.
(9)加入250μL无水乙醇,充分振荡混匀15s。(9) Add 250 μL of absolute ethanol, shake well to mix for 15 s.
(10)将上一步所得溶液和絮状沉淀都加入一个吸附柱中,12000r/min离心30s,倒掉废液,将吸附柱放入收集管中。(10) Add the solution and flocculent precipitate obtained in the previous step to an adsorption column, centrifuge at 12000r/min for 30s, pour off the waste liquid, and put the adsorption column into the collection tube.
(11)向吸附柱中加入500μL缓冲液C,12000r/min离心30s,倒掉废液,将吸附柱放入收集管中。(11) Add 500 μL of buffer C to the adsorption column, centrifuge at 12000 r/min for 30 s, discard the waste solution, and place the adsorption column in the collection tube.
(12)向吸附柱中加入700μL缓冲液W2,离心30s,倒掉废液,将吸附柱放入收集管中。(12) Add 700 μL of buffer W2 to the adsorption column, centrifuge for 30 s, discard the waste solution, and place the adsorption column in the collection tube.
(13)向吸附柱中加入500μL缓冲液W2,12000r/min离心3min,倒掉废液。(13) Add 500 μL of buffer W2 to the adsorption column, centrifuge at 12000 r/min for 3 min, and discard the waste solution.
(14)将吸附柱放入一个干净的离心管中,室温放置数分钟,向吸附膜的中间部位悬空滴加150μL洗脱液TE,室温放置5min,12000r/min离心2min,将溶液收集到离心管中。(14) Place the adsorption column in a clean centrifuge tube and place it at room temperature for several minutes. Add 150 μL of eluent TE to the middle part of the adsorption membrane, place it at room temperature for 5 min, centrifuge at 12000 r/min for 2 min, and collect the solution into the centrifuge. In the tube.
1.2地衣芽孢杆菌CotA蛋白编码基因扩增,步骤如下:1.2 Amplification of CotA protein encoding gene of Bacillus licheniformis, the steps are as follows:
依照载体PET-31b多克隆位点,选择NdeI和XhoI为酶切位点,设计上游引物P1和下游引物P2,由上海生工生物工程技术有限公司合成。设计上游引物P1和下游引物P2序列如下:According to the multi-cloning site of the PET-31b vector, NdeI and XhoI were selected as the restriction sites, and the upstream primer P1 and downstream primer P2 were designed and synthesized by Shanghai Shengong Bioengineering Technology Co., Ltd. Design the sequence of upstream primer P1 and downstream primer P2 as follows:
上游引物P1:5′ATGAAACTTGAAAAATTCGTTG3′Upstream primer P1: 5′ATGAAACTTGAAAAATTCGTTG3′
下游引物P2:5′TTATTGATGACGAACATCTG3′Downstream primer P2: 5′TTATTGATGACGAACATCTG3′
以地衣芽孢杆菌基因组DNA为模板进行扩增,其反应条件为:The genomic DNA of Bacillus licheniformis was used as the template for amplification. The reaction conditions were:
DNA模板DNA template 1μL1μL
上游引物P1Upstream primer P1 2μL2μL
下游引物P2Downstream primer P2 2μL2μL
2×Pfu PCR Mix2×Pfu PCR Mix 25μL25μL
ddH 2O 2 ddH 2 O 2 20μL20μL
总体积total capacity 50μL50μL
扩增条件为:95℃预变性5min;95℃变性30s;50℃退火30s,72℃延伸1min 30s反应30个循环;72℃彻底延伸10min。PCR扩增产物经1%琼脂糖凝胶电泳,用琼脂糖凝胶DNA回收试剂盒回收PCR产物。The amplification conditions were: pre-denaturation at 95℃ for 5min; denaturation at 95℃ for 30s; annealing at 50℃ for 30s, extension at 72℃ for 1min and 30s reaction for 30 cycles; 72℃ for complete extension for 10min. The PCR amplified products were subjected to 1% agarose gel electrophoresis, and the PCR products were recovered using agarose gel DNA recovery kit.
2、含有CotA蛋白编码基因序列的重组表达载体构建2. Construction of recombinant expression vector containing CotA protein coding gene sequence
用NdeI和XhoI双酶切上一步回收的PCR产物以及PET-31b质粒,酶切体系如下:The PCR product recovered in the previous step and the PET-31b plasmid were digested with NdeI and XhoI, and the digestion system was as follows:
Figure PCTCN2019095955-appb-000001
Figure PCTCN2019095955-appb-000001
酶切条件为:37℃水浴30min。酶切产物经1%琼脂糖凝胶电泳,用琼脂糖凝胶DNA回收试剂盒回收PCR产物和质粒酶切片段。Digestion conditions: 37°C water bath for 30min. The digested product was subjected to 1% agarose gel electrophoresis, and the PCR product and plasmid digested fragments were recovered using an agarose gel DNA recovery kit.
上述酶切回收的PCR产物和质粒经T4DNA连接酶16℃连接过夜;连接产物转化大肠杆菌感受态细胞DH5α,经Amp抗性平板筛选,挑取阳性转化子,提取转化质粒,并进行单、双酶切验证和测序,确定构建获得正确的重组菌株DH5α/PET-31b-CotA。The PCR product and plasmid recovered by the above digestion were ligated overnight at 16°C with T4 DNA ligase; the ligation product was transformed into E. coli competent cell DH5α, screened by Amp resistant plate, positive transformants were picked, the transformed plasmid was extracted, and single and double Digestion verification and sequencing confirmed that the correct recombinant strain DH5α/PET-31b-CotA was obtained.
3、CotA蛋白在大肠杆菌中的诱导表达和纯化3. Induced expression and purification of CotA protein in E. coli
3.1 CotA蛋白诱导表达3.1 CotA protein induced expression
将转化有PET-31b-CotA质粒的重组大肠杆菌Rosseta(DE3)接种于5mL液体LB培养基中活化过夜,按1∶100比例转接到500mL装液量为300mL的三角瓶中,180r/min,37℃条件下培养至OD600为0.6,添加终浓度为0.1mM IPTG诱导目的蛋白表达。The recombinant E. coli Rosseta (DE3) transformed with PET-31b-CotA plasmid was inoculated in 5mL liquid LB medium for activation overnight, and transferred to a 500mL Erlenmeyer flask with a volume of 300mL at a ratio of 1:100, 180r/min Incubate at 37°C until the OD600 is 0.6, add a final concentration of 0.1mM IPTG to induce the expression of the target protein.
3.2 CotA蛋白纯化3.2 CotA protein purification
收集发酵液,4℃,12000rpm离心30min,弃上清;用pH7.0的磷酸缓冲液重悬菌体,4℃,12000rpm离心30min,弃上清,重复洗涤菌体三次。然后将菌体细胞重悬在1mg/mL的binding buffer中,超声破碎,4℃,12000rpm离心10min,收集上清并过滤。由于表达的CotA蛋白C端带有组氨酸标签(6×His),因此使用镍离子亲和层析柱(Ni2 +-NTA)纯化重组蛋白,平衡、上样、洗脱等步骤参见Qiagen使用手册。纯化后的蛋白用截留管(10kDa)超滤去除其中含有的咪唑,采用SDS-PAGE电泳检测目的蛋白的纯化结果,结果如图1所示,泳道1为表达产物,箭头表示目的条带,这表明重组菌株表达的蛋白质的分子量约为60kDa,与理论分子量大小一致。 The fermentation broth was collected, centrifuged at 12000rpm for 30min at 4°C, and the supernatant was discarded; the cells were resuspended with phosphate buffer at pH 7.0, centrifuged at 12000rpm for 30min at 4°C, the supernatant was discarded, and the cells were washed three times. The bacterial cells were then resuspended in a binding buffer of 1 mg/mL, sonicated, centrifuged at 12000 rpm for 10 min at 4°C, and the supernatant was collected and filtered. Because the C-terminus of the expressed CotA protein carries a histidine tag (6×His), a nickel ion affinity chromatography column (Ni2 + -NTA) was used to purify the recombinant protein. For equilibration, loading, and elution steps, see Qiagen. manual. The purified protein was ultrafiltered with a retention tube (10kDa) to remove the imidazole contained therein. The purification result of the target protein was detected by SDS-PAGE electrophoresis. The result is shown in Figure 1. Lane 1 is the expression product, and the arrow indicates the target band. It shows that the molecular weight of the protein expressed by the recombinant strain is about 60 kDa, which is consistent with the theoretical molecular weight.
实施例2 CotA蛋白对黄曲霉毒素B1和玉米赤霉烯酮降解活性检测Example 2 Detection of degradation activity of CotA protein on aflatoxin B1 and zearalenone
将黄曲霉毒素B1溶解到二甲基亚砜中配成20μg/mL的母液,按如下500μL反应体系进行试验:430μL磷酸钠缓冲液(0.1M,pH8.0),20μL CotA蛋白(10μg),50μL黄曲霉毒素B1溶液。以未加入CotA蛋白的体系作为对照。反应在37℃下进行12h后加入500μL甲醇终止反应,采用高效液相色谱检测AFB1,根据AFB1浓度的变化来分析CotA蛋白对AFB1是否具有降解活性。Dissolve aflatoxin B1 in dimethyl sulfoxide to make a 20 μg/mL mother liquor, and test according to the following 500 μL reaction system: 430 μL sodium phosphate buffer (0.1 M, pH 8.0), 20 μL CotA protein (10 μg), 50 μL of aflatoxin B1 solution. The system without CotA protein was used as a control. After the reaction was carried out at 37°C for 12h, 500 μL of methanol was added to terminate the reaction. AFB1 was detected by high-performance liquid chromatography. According to the change of AFB1 concentration, whether the CotA protein had degradation activity on AFB1 was analyzed.
高效液相色谱检测AFB1的色谱条件为:色谱柱:Agilent C18色谱柱,4.6mm×150mm×5μm;流动相:甲醇-水(45∶55);流速:1mL/min;泵压:75bar;进样量:20μL;荧光检测器检测波长:λex=360nm,λem=440nm;采集时间:20分钟。The chromatographic conditions for high performance liquid chromatography detection of AFB1 are: chromatographic column: Agilent C18 column, 4.6mm×150mm×5μm; mobile phase: methanol-water (45:55); flow rate: 1mL/min; pump pressure: 75bar; Sample volume: 20 μL; detection wavelength of fluorescence detector: λex=360 nm, λem=440 nm; collection time: 20 minutes.
在上述色谱条件下,如图2所示,对照组样品在保留时间RT=12.4min处有强吸收峰,而加入CotA蛋白组基本无AFB1目标峰检出,经吸收峰面积计算,已有95%的AFB1分子被降解,表明重组CotA蛋白具有降解 黄曲霉毒素B1的活性。Under the above chromatographic conditions, as shown in Figure 2, the control sample has a strong absorption peak at the retention time RT = 12.4min, but the addition of the CotA protein group basically has no AFB1 target peak detected. According to the absorption peak area calculation, there are already 95 % AFB1 molecules are degraded, indicating that the recombinant CotA protein has the activity of degrading aflatoxin B1.
将玉米赤霉烯酮溶解到乙腈中配成100μg/mL的母液,按如下500μL反应体系进行试验:430μL磷酸钠缓冲液(0.1M,pH8.0),20μL CotA蛋白(10μg),50μL玉米赤霉烯酮溶液。以未加入CotA蛋白的体系作为对照。反应在37℃下进行12h后加入500μL甲醇终止反应,采用高效液相色谱检测,根据ZEN浓度的变化来分析CotA蛋白对ZEN是否具有降解活性。Dissolve zearalenone in acetonitrile to make a 100 μg/mL mother liquor, and test according to the following 500 μL reaction system: 430 μL sodium phosphate buffer (0.1 M, pH 8.0), 20 μL CotA protein (10 μg), 50 μL corn red Mycophenone solution. The system without CotA protein was used as a control. After the reaction was carried out at 37°C for 12h, 500 μL of methanol was added to terminate the reaction. High performance liquid chromatography was used to detect whether the CotA protein had degrading activity on ZEN according to the change of ZEN concentration.
高效液相色谱检测ZEN的色谱条件为:色谱柱:Agilent C18色谱柱,4.6mm×150mm×5μm;流动相:乙腈-水-甲醇(46∶46∶8);流速:1mL/min;泵压:45bar;进样量:20μL;荧光检测器检测波长:λex=274nm,λem=440nm;采集时间:18分钟。The chromatographic conditions for high performance liquid chromatography detection of ZEN are: Column: Agilent C18 column, 4.6mm×150mm×5μm; Mobile phase: acetonitrile-water-methanol (46:46:8); flow rate: 1mL/min; pump pressure : 45 bar; injection volume: 20 μL; detection wavelength of fluorescence detector: λex=274 nm, λem=440 nm; collection time: 18 minutes.
在上述色谱条件下,如图3所示,对照组样品在保留时间RT=12.2min处有强吸收峰,而加入CotA蛋白组基本无ZEN目标峰检出,经吸收峰面积计算,已有95%的ZEN分子被降解,表明重组CotA蛋白具有降解玉米赤霉烯酮的活性。Under the above chromatographic conditions, as shown in Fig. 3, the control sample had a strong absorption peak at the retention time RT = 12.2min, but the addition of CotA protein group basically did not detect the ZEN target peak. According to the calculation of the absorption peak area, there are already 95 % Of the ZEN molecules are degraded, indicating that the recombinant CotA protein has the activity of degrading zearalenone.
实施例3 pH对CotA蛋白降解黄曲霉毒素B1和玉米赤霉烯酮活性的影响Example 3 The effect of pH on the degradation of aflatoxin B1 and zearalenone by CotA protein
为测试在不同pH条件下CotA蛋白降解AFB1活性,采用案例实施2所用的反应体系:430μL缓冲液(0.1M柠檬酸钠缓冲液,pH5-6;0.1M磷酸钠缓冲液,pH7-8;0.1M甘氨酸-NaOH缓冲液,pH9),20μL CotA蛋白(10μg),50μL黄曲霉毒素B1溶液。反应在37℃下进行不同时间(1、3、6、9、12h)后加入500μL甲醇终止反应,采用案例实施2所述方法检测体系中残留的AFB1含量。结果如图4所示,在中性及偏碱性条件下,CotA蛋白降解AFB1活性相对较高,最适pH为8.0。To test the activity of CotA protein degrading AFB1 under different pH conditions, the reaction system used in Case Example 2: 430 μL buffer (0.1M sodium citrate buffer, pH 5-6; 0.1M sodium phosphate buffer, pH 7-8; 0.1 M glycine-NaOH buffer, pH 9), 20 μL CotA protein (10 μg), 50 μL aflatoxin B1 solution. After the reaction was carried out at 37°C for different time (1, 3, 6, 9, 12h), 500 μL of methanol was added to terminate the reaction, and the method described in Case 2 was used to detect the residual AFB1 content in the system. The results are shown in Figure 4. Under neutral and alkaline conditions, CotA protein degrades AFB1 with relatively high activity, and the optimal pH is 8.0.
为测试在不同pH条件下CotA蛋白降解ZEN活性,采用案例实施2所用的反应体系:430μL缓冲液(0.1M柠檬酸钠缓冲液,pH6;0.1M磷酸钠缓冲液,pH7-8;0.1M甘氨酸-NaOH缓冲液,pH9-10),20μL CotA蛋白(10μg),50μL玉米赤霉烯酮溶液。反应在37℃下进行不同时间(1、3、6、9、12h)后加入500μL甲醇终止反应,采用案例实施2所述方法检测体 系中残留的ZEN含量。结果如图4所示,在中性及偏碱性条件下,CotA蛋白降解ZEN活性相对较高,最适pH为8.0。To test the activity of CotA protein degrading ZEN under different pH conditions, the reaction system used in Case Example 2: 430 μL buffer (0.1M sodium citrate buffer, pH6; 0.1M sodium phosphate buffer, pH7-8; 0.1M glycine -NaOH buffer, pH 9-10), 20 μL CotA protein (10 μg), 50 μL zearalenone solution. After the reaction was carried out at 37°C for different time (1, 3, 6, 9, 12h), 500 μL of methanol was added to terminate the reaction. The method described in Case Example 2 was used to detect the residual ZEN content in the system. The results are shown in Figure 4. Under neutral and alkaline conditions, CotA protein degrades ZEN with relatively high activity, and the optimal pH is 8.0.
实施例4 温度对CotA蛋白降解黄曲霉毒素B1和玉米赤霉烯酮活性的影响Example 4 The effect of temperature on the degradation of aflatoxin B1 and zearalenone by CotA protein
为测试在不同温度条件下CotA蛋白降解AFB1和ZEN活性,采用案例实施2所用的反应体系:430μL缓冲液(0.1M磷酸钠缓冲液,pH8),20μL CotA蛋白(10μg),50μL黄曲霉毒素B1溶液或玉米赤霉烯酮溶液。反应在不同温度(30、40、50、60、65、70、75、80℃)条件下进行30min后加入500μL甲醇终止反应,采用案例实施2所述方法检测体系中残留的毒素含量。结果如图5所示CotA蛋白降解AFB1最适温度为70℃,降解ZEN最适温度为75℃。To test the activity of CotA protein to degrade AFB1 and ZEN under different temperature conditions, the reaction system used in Case Example 2 was used: 430 μL buffer (0.1M sodium phosphate buffer, pH8), 20 μL CotA protein (10 μg), 50 μL aflatoxin B1 Solution or zearalenone solution. The reaction was carried out at different temperatures (30, 40, 50, 60, 65, 70, 75, 80°C) for 30 minutes, and then 500 μL of methanol was added to terminate the reaction. The method described in Case 2 was used to detect the residual toxin content in the system. The results are shown in Figure 5. The optimal temperature for CotA protein degradation AFB1 is 70℃, and the optimal temperature for ZEN degradation is 75℃.
实施例5 CotA蛋白降解黄曲霉毒素B1和玉米赤霉烯酮酶促反应动力学参数测定Example 5 CotA protein degradation of aflatoxin B1 and zearalenone enzymatic reaction kinetic parameter determination
CotA蛋白降解黄曲霉毒素B1和玉米赤霉烯酮酶活定义为,每分钟降解1μg毒素所需要的酶量。CotA protein degradation of aflatoxin B1 and zearalenone enzyme activity is defined as the amount of enzyme required to degrade 1 μg of toxin per minute.
采用案例实施2所用的500μL反应体系:430μL缓冲液(0.1M磷酸钠缓冲液,pH8),20μL CotA蛋白(10μg),50μL黄曲霉毒素B1溶液,其中AFB1终浓度分别为1、2、5、10、25、40、50、75和100μg/mL,37℃反应30min;测定不同浓度AFB1体系中CotA催化降解AFB1的初始反应速率,根据米氏方程,用Graphpad5.0进行Michaelis-Menten回归分析,求解CotA催化降解AFB1的K m和最大反应速率V m,根据体系中加入的酶量,进一步求解K cat值。同样地,在ZEN浓度为5、10、25、50、100、150、200、300、400μg/mL体系中,测定CotA催化降解ZEN初始反应速率,求解对应的酶促反应动力学参数。结果如表1所示。 Using the 500 μL reaction system used in Case Example 2: 430 μL buffer (0.1 M sodium phosphate buffer, pH 8), 20 μL CotA protein (10 μg), 50 μL aflatoxin B1 solution, in which the final concentration of AFB1 was 1, 2, 5, 10, 25, 40, 50, 75 and 100 μg/mL, 37°C for 30 min; determine the initial reaction rate of CotA catalytic degradation of AFB1 in different concentrations of AFB1 system, according to the Mie equation, use Graphpad5.0 to perform Michaelis-Menten regression analysis, The K m and the maximum reaction rate V m of CotA catalytic degradation of AFB1 are solved. According to the amount of enzyme added in the system, the K cat value is further solved. Similarly, in a system with ZEN concentrations of 5, 10, 25, 50, 100, 150, 200, 300, and 400 μg/mL, the initial reaction rate of CotA for catalytic degradation of ZEN is determined, and the corresponding kinetic parameters of the enzymatic reaction are solved. The results are shown in Table 1.
表1 为CotA催化降解黄曲霉毒素B1和玉米赤霉烯酮反应动力学参数Table 1 shows the kinetic parameters of CotA catalytic degradation of aflatoxin B1 and zearalenone
Figure PCTCN2019095955-appb-000002
Figure PCTCN2019095955-appb-000002
实施例6 CotA催化降解AFM1、AFG1、玉米赤霉烯醇和玉米赤霉醇的效率Example 6 CotA catalytic degradation efficiency of AFM1, AFG1, zearalenol and zearalenol
将AFM1、AFG1、玉米赤霉烯醇和玉米赤霉醇分别溶解到二甲基亚砜中配成20μg/mL的母液,按如下500μL反应体系进行试验:430μL磷酸钠缓冲液(0.1M,pH6.0-8.0),20μL CotA蛋白(10μg),50μL各种毒素母液。以未加入CotA蛋白的体系作为对照。反应在37℃下进行12h后加入500μL甲醇终止反应,采用高效液相色谱检测,根据各毒素浓度的变化来分析CotA蛋白对几类毒素是否具有降解活性。具体实施方案如实施例2,CotA催化降解AFM1、AFG1、玉米赤霉烯醇和玉米赤霉醇的效率见表2。The AFM1, AFG1, zearalenol and zearalenol were dissolved in dimethyl sulfoxide to make a 20μg/mL mother liquor, and the test was carried out according to the following 500μL reaction system: 430μL sodium phosphate buffer (0.1M, pH6. 0-8.0), 20 μL CotA protein (10 μg), 50 μL mother liquid of various toxins. The system without CotA protein was used as a control. After the reaction was carried out at 37°C for 12h, 500 μL of methanol was added to terminate the reaction. High-performance liquid chromatography was used to detect whether the CotA protein had degrading activity against several toxins according to the change in the concentration of each toxin. Specific embodiments are as in Example 2. The efficiency of CotA for catalytic degradation of AFM1, AFG1, zearalenol and zearalenol is shown in Table 2.
表2 CotA催化降解AFM1、AFG1、玉米赤霉烯醇和玉米赤霉醇的效率Table 2 CotA catalytic degradation efficiency of AFM1, AFG1, zearalenol and zearalenol
Figure PCTCN2019095955-appb-000003
Figure PCTCN2019095955-appb-000003
实施例7 一种添加剂及其制备方法Example 7 An additive and preparation method thereof
称取添加剂总质量的90%的载体(麦芽糖糊精与滑石粉按质量比2∶1比例混合),然后再按添加剂总质量的10%的比例混入细菌漆酶CotA蛋白,得到添加剂。Weigh the carrier of 90% of the total mass of the additive (maltodextrin and talc mixed at a mass ratio of 2:1), and then mix the bacterial laccase CotA protein at a ratio of 10% of the total mass of the additive to obtain the additive.
实施例8 一种添加剂及其制备方法Example 8 An additive and preparation method thereof
称取添加剂总质量的9%的载体(麦芽糖糊精与滑石粉按质量比1∶1比例混合),然后再按添加剂总质量的1%的比例混入细菌漆酶CotA蛋白, 最后按添加剂总量的90%混入地衣芽孢杆菌和解淀粉芽孢杆菌混合制剂粉(地衣芽孢杆菌和解淀粉芽孢杆菌质量比为1∶1),得到添加剂。Weigh the carrier of 9% of the total mass of the additive (maltodextrin and talc powder are mixed in a mass ratio of 1:1), then mix in the bacterial laccase CotA protein at a ratio of 1% of the total mass of the additive, and finally according to the total amount of the additive 90% of the mixture was mixed with Bacillus licheniformis and Bacillus amyloliquefaciens mixed preparation powder (the mass ratio of Bacillus licheniformis and Bacillus amyloliquefaciens was 1:1) to obtain additives.
实施例9 一种添加剂及其制备方法Example 9 An additive and preparation method thereof
先将占添加剂总质量的70%的淀粉与占添加剂总质量的10%的枯草芽孢杆菌混合,然后再按添加剂总质量的10%的比例混入细菌漆酶CotA蛋白,最后按添加剂总量的10%混入玉米赤霉烯酮内酯酶,得到添加剂。First, 70% of the total mass of the additive is mixed with 10% of the total mass of the additive, and then the bacterial laccase CotA protein is mixed in the proportion of 10% of the total mass of the additive, and finally 10% of the total amount of the additive % Is mixed with zearalenone lactone enzyme to obtain additives.
实施例10 一种添加剂及其制备方法Example 10 An additive and its preparation method
先将占添加剂总质量的70%麦芽糖糊精与占添加剂总质量的20%的嗜酸乳杆菌混合,然后再按添加剂总质量的5%的比例混入固体细菌漆酶CotA蛋白,最后按添加剂总量的5%混入黄曲霉毒素去毒酶,得到添加剂。First mix 70% of the total mass of the additive with maltodextrin and 20% of the total mass of the additive, then mix the solid bacterial laccase CotA protein at a ratio of 5% of the total mass of the additive, and finally add the total amount of the additive The amount of 5% is mixed with aflatoxin detoxification enzyme to obtain additives.
实施例11Example 11
用实施例8所述的添加剂处理自然霉变玉米中的AFB1。AFB1 in naturally moldy corn was treated with the additives described in Example 8.
将添加剂与自然霉变的玉米(AFB1=50ppb)按0.1%比例混合,在体外模拟动物胃肠液中消化24h,用于降解自然霉变谷物、粮食或饲料中的AFB1。The additive is mixed with natural moldy corn (AFB1=50ppb) at a ratio of 0.1%, and digested for 24 hours in in vitro simulated animal gastrointestinal fluid, which is used to degrade AFB1 in natural moldy grain, grain or feed.
模拟胃液:准确称取2g含有自然霉变AFB1的玉米,再添加2mg添加剂,放入100mL锥形瓶中,加入25mL PBS(0.1M pH6.0),调pH到6.8,混匀。加入1mL配制好的淀粉酶溶液,39℃,150r/min消化2h。加10mL 0.2M HCl,用1M HCl或1M NaOH溶液调pH至2.0,加1mL新鲜配制的酸性蛋白酶(50000U/g),混匀,用parafilm封口,于39℃恒温摇床培养6h(150r/min)。Simulated gastric juice: accurately weigh 2g of corn containing naturally moldy AFB1, then add 2mg of additive, put it in a 100mL Erlenmeyer flask, add 25mL of PBS (0.1M pH6.0), adjust the pH to 6.8, and mix well. Add 1mL of prepared amylase solution, and digest at 39℃, 150r/min for 2h. Add 10mL of 0.2M HCl, adjust the pH to 2.0 with 1M HCl or 1M NaOH solution, add 1mL of freshly prepared acid protease (50000U/g), mix well, seal with parafilm, and incubate at 39℃ for 6h (150r/min) ).
模拟小肠液:模拟胃液孵育6h以后,再加入5mL 0.6M NaOH溶液,用1M HCl或1M NaOH将pH调到6.8后加入新鲜配制的肠道外源酶混悬液(蛋白酶∶淀粉酶∶脂肪酶=3∶1∶1),用parafilm封口,于39℃恒温摇床分别培养18h(150r/min)。Simulated intestinal juice: After 6 hours of simulated gastric juice incubation, add 5mL of 0.6M NaOH solution, adjust the pH to 6.8 with 1M HCl or 1M NaOH, then add freshly prepared intestinal exogenous enzyme suspension (protease: amylase: lipase = 3:1:1), sealed with parafilm, and cultivated on a constant temperature shaker at 39℃ for 18h (150r/min) respectively.
反应结束后测定自然霉变玉米中AFB1的降解率为91.24%。After the reaction, the degradation rate of AFB1 in natural moldy corn was determined to be 91.24%.
实施例12Example 12
用实施例8所述的添加剂处理工业乙醇加工副产物DDGS中的ZEN。The ZEN in the industrial ethanol processing by-product DDGS was treated with the additives described in Example 8.
将添加剂与工业乙醇加工副产物DDGS(ZEN=3ppm)按0.1%比例 混合,在体外模拟动物胃肠液中消化24h,用于降解DDGS中的ZEN。The additive is mixed with DDGS (ZEN=3ppm), a by-product of industrial ethanol processing, at a ratio of 0.1%, and digested in the in vitro simulated animal gastrointestinal fluid for 24h to degrade ZEN in DDGS.
模拟胃液:准确称取2gZEN霉变的DDGS,再添加2mg添加剂,放入100mL锥形瓶中,加入25mL PBS(0.1M pH6.0),调pH到6.8,混匀。加入1mL配制好的淀粉酶溶液,39℃,150r/min消化2h。加10mL 0.2M HCl,用1M HCl或1M NaOH溶液调pH至2.0,加1mL新鲜配制的酸性蛋白酶(50000U/g),混匀,用parafilm封口,于39℃恒温摇床培养6h(150r/min)。Simulated gastric juice: accurately weigh 2g of ZEN mildewed DDGS, add 2mg of additive, put it in a 100mL Erlenmeyer flask, add 25mL of PBS (0.1M pH 6.0), adjust the pH to 6.8, and mix well. Add 1mL of prepared amylase solution, and digest at 39℃, 150r/min for 2h. Add 10mL 0.2M HCl, adjust the pH to 2.0 with 1M HCl or 1M NaOH solution, add 1mL of freshly prepared acidic protease (50000U/g), mix well, seal with parafilm, and incubate at 39℃ for 6h (150r/min) ).
模拟小肠液:模拟胃液孵育6h以后,再加入5mL 0.6M NaOH溶液,用1M HCl或1M NaOH将pH调到6.8后加入新鲜配制的肠道外源酶混悬液(蛋白酶∶淀粉酶∶脂肪酶=3∶1∶1),用parafilm封口,于39℃恒温摇床分别培养18h(150r/min)。Simulated small intestinal juice: After 6 hours of simulated gastric juice incubation, add 5mL 0.6M NaOH solution, adjust the pH to 6.8 with 1M HCl or 1M NaOH, then add freshly prepared intestinal exogenous enzyme suspension (protease: amylase: lipase = 3:1:1), sealed with parafilm, and cultivated on a constant temperature shaker at 39℃ for 18h (150r/min) respectively.
反应结束后测定霉变的DDGS中ZEN的降解率为93.23%。After the reaction was completed, the degradation rate of ZEN in moldy DDGS was determined to be 93.23%.
以上对本发明所提供的细菌漆酶CotA蛋白在降解霉菌毒素中的应用进行了详细介绍。本文应用了具体个例对本发明的原理及实施方式进行了阐述,以上实施例的说明只是用于帮助理解本发明的方法及其核心思想。应当指出,对于本技术领域技术人员来说,在不脱离本发明原理的前提下,还可以对本发明进行若干改进和修饰,这些改进和修饰也落入本发明权利要求的保护范围内。The application of the bacterial laccase CotA protein provided by the present invention in the degradation of mycotoxins has been described in detail above. This document uses specific examples to explain the principles and implementations of the present invention. The descriptions of the above examples are only used to help understand the method and core ideas of the present invention. It should be noted that, for those skilled in the art, without departing from the principle of the present invention, the present invention may also be subjected to several improvements and modifications, and these improvements and modifications also fall within the protection scope of the claims of the present invention.

Claims (31)

  1. 细菌漆酶CotA蛋白,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:The bacterial laccase CotA protein is characterized in that the amino acid sequence of the bacterial laccase CotA protein is:
    如SEQ ID NO.1所示序列;As shown in SEQ ID NO.1 sequence;
    或者如SEQ ID NO.1所示序列中的一个或两个氨基酸残基被取代和/或缺失和/或插入;Or one or two amino acid residues in the sequence shown in SEQ ID NO. 1 are substituted and/or deleted and/or inserted;
    或者与SEQ ID NO:1所示的氨基酸序列具有至少90%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。Or a sequence having at least 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of bacterial laccase CotA protein.
  2. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少70%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The bacterial laccase CotA protein according to claim 1, wherein the amino acid sequence of the bacterial laccase CotA protein has at least 70% sequence identity with the amino acid sequence shown in SEQ ID NO:1, And it has the function sequence of bacterial laccase CotA protein.
  3. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少75%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The bacterial laccase CotA protein according to claim 1, wherein the bacterial laccase CotA protein has an amino acid sequence of at least 75% sequence identity with the amino acid sequence shown in SEQ ID NO:1, And it has the function sequence of bacterial laccase CotA protein.
  4. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少80%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The bacterial laccase CotA protein according to claim 1, wherein the bacterial laccase CotA protein has an amino acid sequence of at least 80% sequence identity with the amino acid sequence shown in SEQ ID NO:1, And it has the function sequence of bacterial laccase CotA protein.
  5. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少85%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The bacterial laccase CotA protein according to claim 1, wherein the amino acid sequence of the bacterial laccase CotA protein has at least 85% sequence identity with the amino acid sequence shown in SEQ ID NO:1, And it has the function sequence of bacterial laccase CotA protein.
  6. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:The bacterial laccase CotA protein according to claim 1, wherein the nucleotide sequence encoding the bacterial laccase CotA protein is:
    如SED ID NO.2所示序列;As shown in the sequence of SEDID NO.2;
    或者如SED ID NO.2所示序列中的一个或两个核苷酸残基被取代和/ 或缺失和/或插入;Or one or two nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
    或者与SEQ ID NO:2所示的核苷酸序列具有至少90%以上的序列一致性。Or it has at least 90% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
  7. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少70%以上的序列一致性。The bacterial laccase CotA protein according to claim 1, wherein the nucleotide sequence encoding the bacterial laccase CotA protein is at least 70% of the nucleotide sequence shown in SEQ ID NO: 2 Sequence consistency.
  8. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少75%以上的序列一致性。The bacterial laccase CotA protein according to claim 1, wherein the nucleotide sequence encoding the bacterial laccase CotA protein is at least 75% of the nucleotide sequence shown in SEQ ID NO: 2 Sequence consistency.
  9. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少80%以上的序列一致性。The bacterial laccase CotA protein according to claim 1, wherein the nucleotide sequence encoding the bacterial laccase CotA protein is at least 80% of the nucleotide sequence shown in SEQ ID NO: 2 Sequence consistency.
  10. 根据权利要求1所述的细菌漆酶CotA蛋白,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少85%以上的序列一致性。The bacterial laccase CotA protein of claim 1, wherein the nucleotide sequence encoding the bacterial laccase CotA protein is at least 85% of the nucleotide sequence shown in SEQ ID NO: 2 Sequence consistency.
  11. 如权利要求1至10任一项所述的细菌漆酶CotA蛋白在降解霉菌毒素上的应用。The use of the bacterial laccase CotA protein according to any one of claims 1 to 10 in the degradation of mycotoxins.
  12. 根据权利要求11所述的应用,其特征在于,所述的霉菌毒素为黄曲霉毒素B1、B2、G1、G2、M1、M2、玉米赤霉烯酮、玉米赤霉烯醇或玉米赤霉醇中的一种或多种。The use according to claim 11, characterized in that the mycotoxins are aflatoxins B1, B2, G1, G2, M1, M2, zearalenone, zearalenol or zearalenol One or more of them.
  13. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白来源于芽孢杆菌,所述芽孢杆菌为地衣芽孢杆菌(Bacillus licheniformis)、枯草芽孢杆菌(Bacillus subtilis)、解淀粉芽孢杆菌(Bacillus amyloliquefaciens)、短小芽胞杆菌(Bacillus pumilus)、迟缓芽孢杆菌(Bacillus lentus)或克劳氏芽胞杆菌(Bacillus clausii),优选为地衣芽孢杆菌(Bacillus licheniformis)。The application according to claim 11, characterized in that the bacterial laccase CotA protein is derived from Bacillus, the Bacillus is Bacillus licheniformis, Bacillus subtilis, Bacillus amyloliquefaciens (Bacillus amyloliquefaciens), Bacillus brevis (Bacillus pumilus), Bacillus lentus (Bacillus lentus) or Bacillus clausii (Bacillus clausii), preferably Bacillus licheniformis.
  14. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:The use according to claim 11, characterized in that the amino acid sequence of the bacterial laccase CotA protein is:
    如SEQ ID NO.1所示序列;As shown in SEQ ID NO.1 sequence;
    或者如SEQ ID NO.1所示序列中的一个或两个氨基酸残基被取代和/或缺失和/或插入;Or one or two amino acid residues in the sequence shown in SEQ ID NO. 1 are substituted and/or deleted and/or inserted;
    或者与SEQ ID NO:1所示的氨基酸序列具有至少90%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。Or a sequence having at least 90% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having the function of bacterial laccase CotA protein.
  15. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少70%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The use according to claim 11, characterized in that the amino acid sequence of the bacterial laccase CotA protein is: at least 70% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has a bacterial lacquer The functional sequence of the enzyme CotA protein.
  16. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少75%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The application according to claim 11, characterized in that the amino acid sequence of the bacterial laccase CotA protein is: at least 75% sequence identity with the amino acid sequence shown in SEQ ID NO: 1, and has a bacterial lacquer The functional sequence of the enzyme CotA protein.
  17. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少80%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The application according to claim 11, characterized in that the amino acid sequence of the bacterial laccase CotA protein is: having at least 80% sequence identity with the amino acid sequence shown in SEQ ID NO: 1 and having a bacterial lacquer The functional sequence of the enzyme CotA protein.
  18. 根据权利要求11所述的应用,其特征在于,所述细菌漆酶CotA蛋白的氨基酸序列为:与SEQ ID NO:1所示的氨基酸序列具有至少85%以上的序列一致性,并具有细菌漆酶CotA蛋白的功能的序列。The application according to claim 11, characterized in that the amino acid sequence of the bacterial laccase CotA protein is at least 85% identical to the amino acid sequence shown in SEQ ID NO: 1, and has a bacterial lacquer The functional sequence of the enzyme CotA protein.
  19. 根据权利要求11所述的应用,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:The use according to claim 11, characterized in that the nucleotide sequence encoding the bacterial laccase CotA protein is:
    如SED ID NO.2所示序列;As shown in the sequence of SEDID NO.2;
    或者如SED ID NO.2所示序列中的一个或两个核苷酸残基被取代和/或缺失和/或插入;Or one or two nucleotide residues in the sequence as shown in SED ID NO. 2 are substituted and/or deleted and/or inserted;
    或者与SEQ ID NO:2所示的核苷酸序列具有至少90%以上的序列一致性。Or it has at least 90% sequence identity with the nucleotide sequence shown in SEQ ID NO:2.
  20. 根据权利要求11所述的应用,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少70%以上的序列一致性。The use according to claim 11, characterized in that the nucleotide sequence encoding the bacterial laccase CotA protein is: at least 70% sequence identity with the nucleotide sequence shown in SEQ ID NO: 2 .
  21. 根据权利要求11所述的应用,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少75%以上的序列一致性。The application according to claim 11, characterized in that the nucleotide sequence encoding the bacterial laccase CotA protein is: having at least 75% sequence identity with the nucleotide sequence shown in SEQ ID NO: 2 .
  22. 根据权利要求11所述的应用,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少80%以上的序列一致性。The application according to claim 11, characterized in that the nucleotide sequence encoding the bacterial laccase CotA protein is: at least 80% sequence identity with the nucleotide sequence shown in SEQ ID NO: 2 .
  23. 根据权利要求11所述的应用,其特征在于,编码所述细菌漆酶CotA蛋白的核苷酸序列为:与SEQ ID NO:2所示的核苷酸序列具有至少85%以上的序列一致性。The application according to claim 11, characterized in that the nucleotide sequence encoding the bacterial laccase CotA protein is at least 85% identical to the nucleotide sequence shown in SEQ ID NO: 2 .
  24. 一种食品或饲料添加剂,其特征在于,包含细菌漆酶CotA蛋白以及其生理上可接受的载体,所述细菌漆酶CotA蛋白的含量为1-10%。A food or feed additive, characterized in that it contains bacterial laccase CotA protein and its physiologically acceptable carrier, and the content of the bacterial laccase CotA protein is 1-10%.
  25. 根据权利要求24所述的食品或饲料添加剂,其特征在于,所述生理上可接受的载体选自麦芽糖糊精、奶粉、石灰石、环糊精、小麦、麦麸、稻米、米糠、蔗糖、淀粉、Na 2SO 4、滑石粉或PVA中的一种或多种。 The food or feed additive according to claim 24, wherein the physiologically acceptable carrier is selected from maltodextrin, milk powder, limestone, cyclodextrin, wheat, wheat bran, rice, rice bran, sucrose, starch , Na 2 SO 4 , talc or one or more of PVA.
  26. 根据权利要求24所述的食品或饲料添加剂,其特征在于,还含有微生态制剂,所述微生态制剂为地衣芽孢杆菌、枯草芽孢杆菌、两歧双歧杆菌、粪肠球菌、屎肠球菌、乳酸肠球菌、嗜酸乳杆菌、干酪乳杆菌、德式乳杆菌乳酸亚种、植物乳杆菌、乳酸片球菌、戊糖片球菌、产朊假丝酵母、婴儿双歧杆菌、长双歧杆菌、短双歧杆菌、青春双歧杆菌、嗜热链球菌、罗伊氏乳杆菌、动物双歧杆菌、米曲霉、迟缓芽孢杆菌、短小芽孢杆菌、纤维二糖乳杆菌、发酵乳杆菌或德氏乳杆菌保加利亚亚种中的一种或多种,优选的,所述饲料添加剂在用于青贮饲料或牛饲料时,还含有产丙酸杆菌、布氏乳杆菌和副干酪乳杆菌中的至少一种;或者所述饲料添加剂在用于禽类、猪和水产养殖动物的饲料时,还含有凝结芽孢杆菌和/或侧孢短芽孢杆菌。The food or feed additive according to claim 24, further comprising a micro-ecological preparation, the micro-ecological preparation is Bacillus licheniformis, Bacillus subtilis, Bifidobacterium bifidus, Enterococcus faecalis, Enterococcus faecium, Enterococcus lactis, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus germani, Lactobacillus plantarum, Lactobacillus plantarum, Pediococcus lactis, Pediococcus pentosus, Candida utilis, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium adolescentis, Streptococcus thermophilus, Lactobacillus reuteri, Bifidobacterium animalis, Aspergillus oryzae, Bacillus lentus, Bacillus pumilus, Lactobacillus cellobiose, Lactobacillus fermentum or Lactobacillus delbrueckii One or more of Bacillus subsp. bulgaricus, preferably, when used in silage or cattle feed, the feed additive further contains at least one of Propionibacterium, Lactobacillus brucelli and Lactobacillus paracasei Or, the feed additive also contains Bacillus coagulans and/or Brevibacillus sp. when used in the feed of poultry, pigs and aquaculture animals.
  27. 根据权利要求24所述的食品或饲料添加剂,其特征在于,所述添加剂还包括另外的酶;所述另外的酶选自:黄曲霉毒素去毒酶、玉米赤霉烯酮内酯酶、伏马毒素羧基酯酶、伏马毒素氨基转移酶、氨基多元醇胺氧化酶、脱氧瓜萎镰菌醇环氧化物水解酶、羧肽酶、黑曲霉天冬氨酸蛋白酶PEPAa、PEPAb、PEPAc或PEPAd,弹性蛋白酶、氨基肽酶、胃蛋白酶、胃蛋白酶样蛋白酶、胰蛋白酶、胰蛋白酶样蛋白酶、细菌蛋白酶、涉及淀粉代谢、纤维降解、脂质代谢的酶、涉及糖原代谢的蛋白质或酶、淀 粉酶、阿拉伯糖酶、阿拉伯呋喃糖酶、过氧化氢酶、纤维素酶、几丁质酶、凝乳酶、角质酶、脱氧核糖核酸酶、表异构酶、酯酶、-半乳糖苷酶、葡聚糖酶、葡聚糖裂解酶、内切葡聚糖酶、葡糖淀粉酶、葡萄糖氧化酶、葡糖苷酶,,葡糖醛酸酶、半纤维素酶、己糖氧化酶、水解酶、转化酶、异构酶、脂解酶、漆酶、裂解酶、甘露糖苷酶、氧化酶、氧化还原酶、果胶酸裂解、果胶乙酰酯酶、果胶去聚合酶、果胶甲酯酶、果胶分解酶、过氧化物酶、酚氧化酶、植酸酶、多聚半乳糖醛酸酶、蛋白酶、鼠李-半乳糖醛酸酶、核糖核酸酶、非洲甜果素、转移酶、转运蛋白、转谷酰胺酶、木聚糖酶、己糖氧化酶或酸性磷酸酶中的一种或多种。The food or feed additive according to claim 24, characterized in that the additive further comprises additional enzymes; the additional enzymes are selected from the group consisting of: aflatoxin detoxification enzyme, zearalenone lactone enzyme, volt Equine toxin carboxylesterase, fumonisin aminotransferase, aminopolyolamine oxidase, deoxyfusarium oxysporum epoxide hydrolase, carboxypeptidase, Aspergillus niger aspartic protease PEPAa, PEPAb, PEPAc or PEPAd , Elastase, aminopeptidase, pepsin, pepsin-like protease, trypsin, trypsin-like protease, bacterial protease, enzymes involved in starch metabolism, fiber degradation, lipid metabolism, proteins or enzymes involved in glycogen metabolism, starch Enzyme, arabinase, arabinofuranase, catalase, cellulase, chitinase, rennet, cutinase, deoxyribonuclease, epimerase, esterase, -galactosidase , Glucanase, glucan lyase, endoglucanase, glucoamylase, glucose oxidase, glucosidase, glucuronidase, hemicellulase, hexose oxidase, hydrolysis Enzyme, invertase, isomerase, lipolytic enzyme, laccase, lyase, mannosidase, oxidase, oxidoreductase, pectate cleavage, pectin acetylesterase, pectin depolymerase, pectin A Esterase, pectin-decomposing enzyme, peroxidase, phenol oxidase, phytase, polygalacturonase, protease, rhamno-galacturonase, ribonuclease, African sweetener, transfer One or more of enzymes, transporters, transglutaminase, xylanase, hexose oxidase, or acid phosphatase.
  28. 一种降解霉菌毒素的方法,其特征在于,包括步骤如下:将细菌漆酶CotA蛋白或权利要求24~27任一项所述的添加剂处理含有霉菌毒素的材料,该素材包括但不限于食品、饲料、饲料原料、粮食、粮油、粮食加工副产品或牛奶。A method for degrading mycotoxins, comprising the steps of treating bacterial laccase CotA protein or the additive according to any one of claims 24 to 27 with a material containing mycotoxins, the material including but not limited to food, Feed, feed materials, grain, grain and oil, grain processing by-products or milk.
  29. 如权利要求28所述的方法,其特征在于,所述素材还包括茶叶,中草药及其加工副产物,工业乙醇加工副产物DDGS,陈化粮,猪、鸡、牛、羊、水产动物用全价饲料、浓缩饲料、预混合饲料、青贮饲料、水产动物饲料、宠物饲料和/或毛皮动物饲料。The method according to claim 28, characterized in that the material further includes tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged food, pig, chicken, cattle, sheep, aquatic animals Feed, concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed.
  30. 权利要求1至10任一项所述的细菌漆酶CotA蛋白或权利要求24~27任一项所述的食品或饲料添加剂在食品和/或饲料中霉菌毒素降解中的应用,其特征在于,所述食品和/或饲料包括但不限于食品、饲料、饲料原料、粮食、粮油、粮食加工副产品或牛奶。The use of the bacterial laccase CotA protein according to any one of claims 1 to 10 or the food or feed additive according to any one of claims 24 to 27 in the degradation of mycotoxins in food and/or feed, characterized in that: The food and/or feed includes but is not limited to food, feed, feed raw materials, grain, grain oil, grain processing by-products or milk.
  31. 权利要求1至10任一项所述的细菌漆酶CotA蛋白或权利要求24~27任一项所述的添加剂在茶叶,中草药及其加工副产物,工业乙醇加工副产物DDGS,陈化粮,猪、鸡、牛、羊、水产动物用全价饲料、浓缩饲料、预混合饲料、青贮饲料、水产动物饲料、宠物饲料和/或毛皮动物饲料中霉菌毒素脱毒中的应用。The bacterial laccase CotA protein according to any one of claims 1 to 10 or the additive according to any one of claims 24 to 27 in tea, Chinese herbal medicine and its processing by-products, industrial ethanol processing by-product DDGS, aged food, Application of mycotoxin detoxification in full-price feed, concentrated feed, pre-mixed feed, silage, aquatic animal feed, pet feed and/or fur animal feed for pigs, chickens, cattle, sheep and aquatic animals.
PCT/CN2019/095955 2018-12-07 2019-07-15 Application of bacterial laccase cota protein in degradation of mycotoxins WO2020113962A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811492897.9 2018-12-07
CN201811492897.9A CN109820132B (en) 2018-12-07 2018-12-07 Application of bacterial laccase CotA protein in degradation of mycotoxin

Publications (1)

Publication Number Publication Date
WO2020113962A1 true WO2020113962A1 (en) 2020-06-11

Family

ID=66859550

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/095955 WO2020113962A1 (en) 2018-12-07 2019-07-15 Application of bacterial laccase cota protein in degradation of mycotoxins

Country Status (2)

Country Link
CN (1) CN109820132B (en)
WO (1) WO2020113962A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111088238A (en) * 2020-02-26 2020-05-01 福州大学 Degraded AFB1Laccase and gene and application thereof
CN113699127A (en) * 2021-08-05 2021-11-26 中国农业科学院北京畜牧兽医研究所 Method for improving mycotoxin degradation rate of dye decolorizing peroxidase
CN114605557A (en) * 2022-03-10 2022-06-10 华南农业大学 Aflatoxin B degradation1And/or zearalenone fusion protein, and preparation method and application thereof
CN115125220A (en) * 2022-07-07 2022-09-30 武汉轻工大学 Laccase EcLac and application thereof, and laccase gene EcLac and application thereof
CN115417507A (en) * 2022-06-21 2022-12-02 江南大学 Laccase for efficiently degrading veterinary drug antibiotic residues and application thereof
CN115779329A (en) * 2022-11-18 2023-03-14 安徽大学 Method for degrading aflatoxin B1 by continuous fed-batch hydrogen peroxide in cooperation with manganese peroxidase

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109820132B (en) * 2018-12-07 2022-07-12 中国农业大学 Application of bacterial laccase CotA protein in degradation of mycotoxin
CN110218708B (en) * 2019-06-20 2021-08-27 天津科技大学 Bacterial laccase and gene, preparation method and application thereof
CN110317758A (en) * 2019-07-19 2019-10-11 河南广安生物科技股份有限公司 Double toxin antidotes of a kind of broiler chicken and preparation method thereof
CN110408662B (en) * 2019-07-31 2021-10-29 中国农业大学 Method for preparing AFQ1 and epi-AFQ1 by oxidizing and catalyzing AFB1 with microbial enzyme
CN110637970B (en) * 2019-09-30 2021-07-20 中国农业科学院北京畜牧兽医研究所 Application of syringaldehyde as mediator participating in degradation of mycotoxin by laccase
CN114586920A (en) * 2022-03-11 2022-06-07 安徽黑娃食品科技有限公司 Sunflower degrading method by using laccaseAflatoxins B in flower seeds1Processing method of
CN115428887A (en) * 2022-10-26 2022-12-06 中科检测技术服务(嘉兴)有限公司 Biological degradation method for mycotoxin in grains or byproducts thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008066931A2 (en) * 2006-11-29 2008-06-05 Novozymes, Inc. Bacillus licheniformis chromosome
CN101903527A (en) * 2007-12-14 2010-12-01 诺维信公司 Process for degrading zearalenone in a feed product employing laccase
CN101959425A (en) * 2008-03-05 2011-01-26 诺维信公司 Detoxification of feed products
CN102154148A (en) * 2010-12-22 2011-08-17 东北林业大学 Laccase from Bacillus licheniformis LS04 and use thereof
CN109820132A (en) * 2018-12-07 2019-05-31 中国农业大学 Application of the bacterial laccase CotA albumen in degradation mycotoxin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104388370A (en) * 2014-11-27 2015-03-04 江南大学 Method for efficient secretory expression of Bacillus pumilus laccase

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008066931A2 (en) * 2006-11-29 2008-06-05 Novozymes, Inc. Bacillus licheniformis chromosome
CN101903527A (en) * 2007-12-14 2010-12-01 诺维信公司 Process for degrading zearalenone in a feed product employing laccase
CN101959425A (en) * 2008-03-05 2011-01-26 诺维信公司 Detoxification of feed products
CN102154148A (en) * 2010-12-22 2011-08-17 东北林业大学 Laccase from Bacillus licheniformis LS04 and use thereof
CN109820132A (en) * 2018-12-07 2019-05-31 中国农业大学 Application of the bacterial laccase CotA albumen in degradation mycotoxin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE Protein 29 August 2013 (2013-08-29), XP055716449, retrieved from ncbi Database accession no. WP_003179495.1 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111088238A (en) * 2020-02-26 2020-05-01 福州大学 Degraded AFB1Laccase and gene and application thereof
CN111088238B (en) * 2020-02-26 2022-09-13 福州大学 Degraded AFB 1 Laccase and gene and application thereof
CN113699127A (en) * 2021-08-05 2021-11-26 中国农业科学院北京畜牧兽医研究所 Method for improving mycotoxin degradation rate of dye decolorizing peroxidase
CN114605557A (en) * 2022-03-10 2022-06-10 华南农业大学 Aflatoxin B degradation1And/or zearalenone fusion protein, and preparation method and application thereof
CN115417507A (en) * 2022-06-21 2022-12-02 江南大学 Laccase for efficiently degrading veterinary drug antibiotic residues and application thereof
CN115417507B (en) * 2022-06-21 2023-10-03 江南大学 Laccase capable of efficiently degrading veterinary drug antibiotic residues and application thereof
CN115125220A (en) * 2022-07-07 2022-09-30 武汉轻工大学 Laccase EcLac and application thereof, and laccase gene EcLac and application thereof
CN115125220B (en) * 2022-07-07 2024-03-01 武汉轻工大学 Laccase EcLac and application thereof, laccase gene EcLac and application thereof
CN115779329A (en) * 2022-11-18 2023-03-14 安徽大学 Method for degrading aflatoxin B1 by continuous fed-batch hydrogen peroxide in cooperation with manganese peroxidase
CN115779329B (en) * 2022-11-18 2024-01-30 安徽大学 Method for degrading aflatoxin B1 by continuous flow hydrogen peroxide and manganese peroxidase

Also Published As

Publication number Publication date
CN109820132A (en) 2019-05-31
CN109820132B (en) 2022-07-12

Similar Documents

Publication Publication Date Title
WO2020113962A1 (en) Application of bacterial laccase cota protein in degradation of mycotoxins
CN110804570B (en) Bacillus beijerinckii for simultaneously degrading zearalenone and aflatoxin and application thereof
CN111073867B (en) Dye decolorization peroxidase BsDyP and application thereof in mycotoxin detoxification
CN108251385B (en) Ochratoxin degrading enzyme, encoding gene, recombinant vector, cell, additive and application thereof
CN108251399B (en) Fumonisin degrading enzyme, encoding gene, recombinant vector, cell, additive and application thereof
CN108251405B (en) Complex enzyme and additive, application thereof and method for removing mycotoxin
Hmani et al. A Bacillus subtilis strain as probiotic in poultry: selection based on in vitro functional properties and enzymatic potentialities
CN112806471A (en) Feed additive composition
Liu et al. Expression of rumen microbial fibrolytic enzyme genes in probiotic Lactobacillus reuteri
AU2018390173B2 (en) Use of Coriobacteriia to promote gut health
US20230138517A1 (en) Feed compositions for animal health
CN113301809A (en) Engineered robust high Tm phytase clade polypeptides and fragments thereof
KR20220121846A (en) Consortium of bacteria comprising at least one Bacillus and Lactobacillus strains for gluten degradation
CN112654703A (en) Xylanase-containing feed additives for cereal-based animal feed
TWI609081B (en) USE OF LACTONE HYDROLASE AND METHOD OF DEGRADING α-ZEARALENOL USING LACTONE HYDORLASE
EP3478831B1 (en) Aspartic proteases
Lokapirnasari et al. Potency of lactic acid bacteria isolated from balinese bovine (Bos sondaicus) intestinal waste from slaughterhouse to improve nutrient content of wheat pollard as animal feedstuff by fermentation process
Su et al. Improved production of spores and bioactive metabolites from Bacillus amyloliquefaciens in solid-state fermentation by a rapid optimization process
CN110621777A (en) Trypsin-like serine protease and uses thereof
CN108348585B (en) Glycoside hydrolases and their use for the prevention and/or treatment of pathogen infections in animals
Liu et al. Direct cloning of a xylanase gene from the mixed genomic DNA of rumen fungi and its expression in intestinal Lactobacillus reuteri
Sharma et al. Evaluation of in vitro probiotic potential of phytase‐producing bacterial strain as a new probiotic candidate
CN102363762B (en) Modified bacillus source and Alpha-amylase gene recombination lactobacillus as well as product and application thereof
Hsueh et al. Increase of the adhesion ability and display of a rumen fungal xylanase on the cell surface of Lactobacillus casei by using a listerial cell‐wall‐anchoring protein
CN114828642A (en) Composition for digestive tract health

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19892541

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19892541

Country of ref document: EP

Kind code of ref document: A1